OKTA, INC., 10-Q filed on 12/1/2022
Quarterly Report
v3.22.2.2
Cover Page - shares
 9 Months Ended
Oct. 31, 2022
Nov. 28, 2022
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Oct. 31, 2022  
Document Transition Report false  
Entity File Number 001-38044  
Entity Registrant Name Okta, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 100 First Street, Suite 600  
Entity Tax Identification Number 26-4175727  
Entity Address, City or Town San Francisco  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94105  
City Area Code 888  
Local Phone Number 722-7871  
Title of 12(b) Security Class A common stock, par value $0.0001 per share  
Trading Symbol OKTA  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Amendment Flag false  
Entity Central Index Key 0001660134  
Current Fiscal Year End Date --01-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Class A Common Stock    
Entity Information [Line Items]    
Entity Common Stock, Shares Outstanding   152,756,525
Class B Common Stock    
Entity Information [Line Items]    
Entity Common Stock, Shares Outstanding   7,426,641
v3.22.2.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Oct. 31, 2022
Jan. 31, 2022
Current assets:    
Cash and cash equivalents $ 249,624 $ 260,134
Short-term investments 2,223,538 2,241,657
Accounts receivable, net of allowances of $7,609 and $4,359 380,754 397,509
Deferred commissions 84,454 74,728
Prepaid expenses and other current assets 68,567 66,605
Total current assets 3,006,937 3,040,633
Property and equipment, net 60,884 65,488
Operating lease right-of-use assets 125,207 147,940
Deferred commissions, noncurrent 195,146 191,029
Intangible assets, net 261,825 316,968
Goodwill 5,400,275 5,401,343
Other assets 43,462 42,294
Total assets 9,093,736 9,205,695
Current liabilities:    
Accounts payable 49,122 20,203
Accrued expenses and other current liabilities 100,086 89,315
Accrued compensation 110,399 143,805
Convertible senior notes, net 5,217 16,194
Deferred revenue 1,044,622 973,289
Total current liabilities 1,309,446 1,242,806
Convertible senior notes, net, noncurrent 2,191,547 1,815,714
Operating lease liabilities, noncurrent 148,906 170,611
Deferred revenue, noncurrent 17,833 22,933
Other liabilities, noncurrent 18,392 31,775
Total liabilities 3,686,124 3,283,839
Commitments and contingencies (Note 11)
Stockholders’ equity:    
Preferred stock, par value $0.0001 per share; 100,000 shares authorized; no shares issued and outstanding as of October 31, 2022 and January 31, 2022 0 0
Additional paid-in capital 7,785,753 7,749,716
Accumulated other comprehensive loss (56,064) (12,009)
Accumulated deficit (2,322,093) (1,815,867)
Total stockholders’ equity 5,407,612 5,921,856
Total liabilities and stockholders' equity 9,093,736 9,205,695
Class A Common Stock    
Stockholders’ equity:    
Common stock 15 15
Class B Common Stock    
Stockholders’ equity:    
Common stock $ 1 $ 1
v3.22.2.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Oct. 31, 2022
Jan. 31, 2022
Allowance for accounts receivable $ 7,609 $ 4,359
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized (in shares) 100,000,000 100,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Class A Common Stock    
Common stock par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 1,000,000,000 1,000,000,000
Common stock, shares issued (in shares) 152,744,000 149,624,000
Common stock, shares outstanding (in shares) 152,744,000 149,624,000
Class B Common Stock    
Common stock par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 120,000,000 120,000,000
Common stock, shares issued (in shares) 7,393,000 6,978,000
Common stock, shares outstanding (in shares) 7,393,000 6,978,000
v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Oct. 31, 2022
Oct. 31, 2021
Revenue:        
Total revenue $ 481,042 $ 350,680 $ 1,347,792 $ 917,186
Cost of revenue:        
Total cost of revenue 137,653 109,674 406,512 276,903
Gross profit 343,389 241,006 941,280 640,283
Operating expenses:        
Research and development 148,484 130,535 465,971 321,805
Sales and marketing 289,984 203,878 807,110 548,749
General and administrative 111,520 105,149 322,549 322,406
Total operating expenses 549,988 439,562 1,595,630 1,192,960
Operating loss (206,599) (198,556) (654,350) (552,677)
Interest expense (2,805) (23,144) (8,588) (68,776)
Interest income and other, net 4,235 1,056 10,660 7,622
Loss on conversion of debt 0 0 0 (179)
Interest and other, net 1,430 (22,088) 2,072 (61,333)
Loss before provision for (benefit from) income taxes (205,169) (220,644) (652,278) (614,010)
Provision for (benefit from) income taxes 3,728 667 9,804 (6,785)
Net loss $ (208,897) $ (221,311) $ (662,082) $ (607,225)
Net loss per share, basic (in dollars per share) $ (1.32) $ (1.44) $ (4.21) $ (4.17)
Net loss per share, diluted (in dollars per share) $ (1.32) $ (1.44) $ (4.21) $ (4.17)
Weighted-average shares outstanding, basic (in shares) 158,708 153,756 157,344 145,782
Weighted-average shares outstanding, diluted (in shares) 158,708 153,756 157,344 145,782
Subscription        
Revenue:        
Total revenue $ 465,856 $ 336,702 $ 1,299,181 $ 879,881
Cost of revenue:        
Total cost of revenue 117,306 91,048 344,524 227,903
Professional services and other        
Revenue:        
Total revenue 15,186 13,978 48,611 37,305
Cost of revenue:        
Total cost of revenue $ 20,347 $ 18,626 $ 61,988 $ 49,000
v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Oct. 31, 2022
Oct. 31, 2021
Statement of Comprehensive Income [Abstract]        
Net loss $ (208,897) $ (221,311) $ (662,082) $ (607,225)
Other comprehensive loss:        
Net change in unrealized gains or losses on available-for-sale securities (7,896) (2,998) (26,595) (4,164)
Foreign currency translation adjustments (6,982) (973) (17,460) (822)
Other comprehensive loss (14,878) (3,971) (44,055) (4,986)
Comprehensive loss $ (223,775) $ (225,282) $ (706,137) $ (612,211)
v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital
Common stock and additional paid-in capital
Adjustment
Accumulated deficit
Accumulated deficit
Adjustment
Accumulated other comprehensive income
Beginning balance at Jan. 31, 2021   $ 1,656,109   $ (967,456)   $ 5,390
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock and value of equity awards assumed in connection with business combination   5,409,344        
Issuance of common stock upon exercise of stock options and other activity, net   64,119        
Stock-based compensation   408,482        
Settlement of convertible senior notes   20,776        
Proceeds from hedges related to convertible senior notes   2        
Net loss $ (607,225)     (607,225)    
Other comprehensive loss           (4,986)
Ending balance at Oct. 31, 2021 5,984,555 7,558,832   (1,574,681)   404
Beginning balance at Jan. 31, 2021   1,656,109   (967,456)   5,390
Ending balance at Jan. 31, 2022 $ 5,921,856 7,749,732 $ (527,444) (1,815,867) $ 155,856 (12,009)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]          
Beginning balance at Jul. 31, 2021   7,391,185   (1,353,370)   4,375
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options and other activity, net   11,208        
Stock-based compensation   156,447        
Settlement of convertible senior notes   (8)        
Net loss $ (221,311)     (221,311)    
Other comprehensive loss           (3,971)
Ending balance at Oct. 31, 2021 5,984,555 7,558,832   (1,574,681)   404
Beginning balance at Jan. 31, 2022 5,921,856 7,749,732 $ (527,444) (1,815,867) $ 155,856 (12,009)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options and other activity, net   36,039        
Stock-based compensation   515,507        
Settlement of convertible senior notes   11,934        
Proceeds from hedges related to convertible senior notes   1        
Net loss (662,082)     (662,082)    
Other comprehensive loss           (44,055)
Ending balance at Oct. 31, 2022 5,407,612 7,785,769   (2,322,093)   (56,064)
Beginning balance at Jul. 31, 2022   7,607,398   (2,113,196)   (41,186)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options and other activity, net   6,088        
Stock-based compensation   172,283        
Settlement of convertible senior notes   0        
Net loss (208,897)     (208,897)    
Other comprehensive loss           (14,878)
Ending balance at Oct. 31, 2022 $ 5,407,612 $ 7,785,769   $ (2,322,093)   $ (56,064)
v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Cash flows from operating activities:    
Net loss $ (662,082) $ (607,225)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Stock-based compensation 511,687 407,611
Depreciation, amortization and accretion 87,999 76,631
Amortization of debt discount and issuance costs 4,340 64,478
Amortization of deferred commissions 60,791 40,041
Deferred income taxes 3,383 (13,606)
Non-cash charitable contributions 2,469 5,649
Lease impairment charges 14,461 0
Loss on conversion of debt 0 179
Net gain on strategic investments (1,873) (5,665)
Other, net 1,872 (267)
Changes in operating assets and liabilities:    
Accounts receivable 14,968 (29,561)
Deferred commissions (82,589) (92,183)
Prepaid expenses and other assets (3,989) 5,356
Operating lease right-of-use assets 20,659 16,564
Accounts payable 29,794 (195)
Accrued compensation (30,629) 19,488
Accrued expenses and other liabilities (5,950) 22,537
Operating lease liabilities (21,782) (17,280)
Deferred revenue 66,233 198,035
Net cash provided by operating activities 9,762 90,587
Cash flows from investing activities:    
Capitalization of internal-use software costs (7,773) (2,348)
Purchases of property and equipment (9,377) (5,800)
Purchases of securities available for sale and other (872,035) (1,333,504)
Proceeds from maturities and redemption of securities available for sale 848,519 1,118,448
Proceeds from sales of securities available for sale and other 0 228,344
Purchases of intangible assets (2,497) (113)
Payments for business acquisitions, net of cash acquired (4,060) (215,129)
Net cash used in investing activities (47,223) (210,102)
Cash flows from financing activities:    
Payments for conversions of convertible senior notes (6) (26)
Proceeds from hedges related to convertible senior notes 1 2
Proceeds from stock option exercises 14,610 41,054
Proceeds from shares issued in connection with employee stock purchase plan 18,960 17,417
Net cash provided by financing activities 33,565 58,447
Effects of changes in foreign currency exchange rates on cash, cash equivalents and restricted cash (9,747) (494)
Net decrease in cash, cash equivalents and restricted cash (13,643) (61,562)
Cash, cash equivalents and restricted cash at beginning of period 272,656 448,630
Cash, cash equivalents and restricted cash at end of period 259,013 387,068
Cash paid during the period for:    
Interest 3,509 3,548
Income taxes 5,445 2,550
Non-cash activities:    
Issuance of common stock and value of equity awards assumed in connection with business combination 0 5,409,344
Issuance of common stock for conversions of convertible senior notes 39,564 126,144
Benefit from exercise of hedges related to convertible senior notes 17,502 92,097
Operating lease right-of-use assets exchanged for lease liabilities 8,442 21,518
Reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows above:    
Cash and cash equivalents 249,624 372,372
Restricted cash, current included in prepaid expenses and other current assets 2,204 5,136
Restricted cash, noncurrent included in other assets 7,185 9,560
Total cash, cash equivalents and restricted cash $ 259,013 $ 387,068
v3.22.2.2
Overview and Basis of Presentation
 9 Months Ended
Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Overview and Basis of Presentation Overview and Basis of Presentation
Description of Business
Okta, Inc. (the “Company”) is the leading independent identity provider. The Okta Workforce Identity and Customer Identity Clouds enable the Company’s customers to securely connect the right people to the right technologies and services at the right time. The Company was incorporated in January 2009 as Saasure Inc., a California corporation, and was later reincorporated in April 2010 under the name Okta, Inc. as a Delaware corporation. The Company is headquartered in San Francisco, California.
Basis of Presentation and Principles of Consolidation
The accompanying unaudited condensed consolidated financial statements, which include the accounts of the Company and its wholly owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim periods. Accordingly, they do not include all of the financial information and footnotes required by GAAP for complete financial statements. All intercompany balances and transactions have been eliminated in consolidation.
The condensed consolidated balance sheet as of January 31, 2022, included herein, was derived from the audited financial statements as of that date. In the opinion of the Company’s management, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary for a fair statement of the results of operations for the interim periods presented but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year ending January 31, 2023 or any future period.
The Company’s fiscal year ends on January 31. References to fiscal 2023, for example, refer to the fiscal year ending January 31, 2023.
The condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 7, 2022.
Certain reclassifications of components of prior period investing cash flows have been made in the condensed consolidated statements of cash flows to conform to the current period presentation. These reclassifications had no impact on the aggregate cash flow classifications as previously reported.
Use of Estimates
The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on other assumptions that its management believes are reasonable under the circumstances. Actual results could vary from those estimates. The Company’s most significant estimates include the stand-alone selling price (“SSP”) for each distinct performance obligation included in customer contracts with multiple performance obligations, the determination of the period of benefit for deferred commissions, the determination of the incremental borrowing rate used for operating lease liabilities, the valuation of deferred income tax assets, the valuation of goodwill and acquired intangible assets and their useful lives and the valuation of certain equity awards assumed.
v3.22.2.2
Accounting Standards and Significant Accounting Policies
 9 Months Ended
Oct. 31, 2022
Accounting Policies [Abstract]  
Accounting Standards and Significant Accounting Policies Accounting Standards and Significant Accounting Policies
Significant Accounting Policies
The Company’s significant accounting policies are discussed in “Note 2. Summary of Significant Accounting Policies” in Item 8. Financial Statements and Supplementary Data of its Form 10-K for the fiscal year ended January 31, 2022. The Company no longer considers the accounting policy for its convertible senior notes to be a significant accounting policy due to the adoption of Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) No. 2020-06 effective February 1, 2022, which simplified the accounting for convertible instruments.
Recently Adopted Accounting Pronouncements
ASU No. 2020-06
The Company adopted the FASB issued ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), effective February 1, 2022, using the modified retrospective method. The prior period condensed consolidated financial statements have not been retrospectively adjusted and continue to be reported under the accounting standards in effect for those periods.
ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity’s own equity. Among other changes, ASU 2020-06 removes from GAAP the liability and equity separation model for convertible instruments with a cash conversion feature, and as a result, after adoption, no longer requires separately presenting in equity an embedded conversion feature for such debt. Similarly, the embedded conversion feature is no longer amortized into income as interest expense over the life of the instrument. Instead, the convertible debt instrument is accounted for wholly as debt unless (1) a convertible instrument contains features that require bifurcation as a derivative, or (2) a convertible debt instrument was issued at a substantial premium. Additionally, ASU 2020-06 requires the application of the if-converted method to calculate the impact of convertible instruments on diluted earnings per share, which is consistent with the Company’s accounting treatment prior to the adoption of ASU 2020-06.
The Company recognized a cumulative effect of initially applying the ASU as an adjustment to the February 1, 2022 opening balance of accumulated deficit. Due to the elimination of the equity conversion component of the Company’s convertible senior notes outstanding as of February 1, 2022, additional paid-in capital was reduced. The elimination of the equity conversion component had the effect of increasing the Company’s net debt balance. The reduction of other liabilities is related to changes to the Company’s deferred tax liabilities.
The adoption of ASU 2020-06 resulted in the following changes to the Company’s condensed consolidated balance sheet as of February 1, 2022:
Balance at
January 31, 2022		Adjustments from Adoption of ASU 2020-06Balance at
February 1, 2022
(dollars in thousands)
Liabilities
Convertible senior notes, net$16,194 $927 $17,121 
Convertible senior notes, net, noncurrent1,815,714 371,527 2,187,241 
Other liabilities, noncurrent31,775 (866)30,909 
Stockholders’ equity
Additional paid-in capital7,749,716 (527,444)7,222,272 
Accumulated deficit(1,815,867)155,856 (1,660,011)
In addition, the adoption of ASU 2020-06 resulted in a decrease in reported net interest expense of approximately $21.2 million and $63.0 million and a decrease in basic and diluted net loss per share of $0.13 and $0.40, for the three and nine months ended October 31, 2022, respectively.
ASU No. 2021-08
The Company adopted the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU 2021-08”), effective February 1, 2022, on a prospective basis. The update requires contract assets and contract liabilities acquired in a business combination be recognized and measured in accordance with ASC Topic 606, Revenue from Contracts with Customers. The adoption of ASU 2021-08 did not have a material impact on the Company’s condensed consolidated financial statements.
ASU No. 2021-04
The Company adopted the FASB issued ASU No. 2021-04, Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (“ASU 2021-04”), effective February 1, 2022, on a prospective basis. ASU 2021-04 addresses specific guidance related to modifications or exchanges of freestanding equity-classified written call options (such as warrants) by specifying the accounting for various modification scenarios. The adoption of ASU 2021-04 did not have a material impact on the Company’s condensed consolidated financial statements.
v3.22.2.2
Business Combinations
 9 Months Ended
Oct. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
Business Combinations Business Combinations
Acquisition of Auth0
On May 3, 2021, the Company acquired all outstanding shares of privately-held Auth0, Inc. (“Auth0”), an Identity-as-a-Service company. Total consideration transferred for Auth0 was $5,671.0 million, including approximately 19.2 million shares of common stock valued at $5,175.6 million, cash of $257.0 million, and assumed outstanding equity awards with vested fair value of $238.4 million. Cash consideration of $3.8 million and approximately 1.1 million shares valued at $294.6 million were held back as partial security for post-closing true-up adjustments as well as any indemnification claims made within one year of the acquisition date. The consideration held back was paid in full during the nine months ended October 31, 2022. The Company incurred $29.0 million of acquisition-related costs, which were recorded as general and administrative expenses in its condensed consolidated statement of operations for the nine months ended October 31, 2021.
The transaction was accounted for as a business combination. The total purchase price of $5,671.0 million was allocated to the tangible and identifiable intangible assets and liabilities based on their estimated fair values. The excess of purchase consideration over the fair value of the net tangible assets and identifiable intangible assets acquired was $5,290.1 million and was recorded as goodwill.
Acquisition of atSpoke
On August 2, 2021, the Company acquired all issued and outstanding capital stock of privately-held Townsend Street Labs, Inc. (“atSpoke”), a modern workplace operations platform. The acquisition date cash consideration for atSpoke was approximately $79.3 million, of which $13.4 million of consideration was held back as partial security for any adjustments and indemnification obligations and will be paid within 18 months of the closing date.
The Company recorded $18.3 million for developed technology intangible assets with an estimated useful life of 3 years and recorded $62.2 million of goodwill. The Company incurred $0.9 million of acquisition-related costs, which were recorded as general and administrative expenses in its condensed consolidated statement of operations in the nine months ended October 31, 2021.
v3.22.2.2
Cash Equivalents and Investments
 9 Months Ended
Oct. 31, 2022
Investments, Debt and Equity Securities [Abstract]  
Cash Equivalents and Investments Cash Equivalents and Investments
Cash Equivalents and Short-term Investments
The following tables present the amortized cost, unrealized gain (loss) and estimated fair value of cash equivalents and short-term investments:
 As of October 31, 2022
 
Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Estimated
Fair Value 
(dollars in thousands)
Cash equivalents:    
Money market funds$91,598 $— $— $91,598 
Total cash equivalents91,598 — — 91,598 
Short-term investments:    
U.S. treasury securities2,032,380 — (34,840)1,997,540 
Corporate debt securities229,491 — (3,493)225,998 
Total short-term investments2,261,871 — (38,333)2,223,538 
Total$2,353,469 $— $(38,333)$2,315,136 
 As of January 31, 2022
 
Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Estimated
Fair Value 
(dollars in thousands)
Cash equivalents:    
Money market funds$152,223 $— $— $152,223 
Total cash equivalents152,223 — — 152,223 
Short-term investments:   
U.S. treasury securities1,922,344 10 (10,166)1,912,188 
Corporate debt securities331,050 — (1,581)329,469 
Total short-term investments2,253,394 10 (11,747)2,241,657 
Total$2,405,617 $10 $(11,747)$2,393,880 

All short-term investments were designated as available-for-sale securities as of October 31, 2022 and January 31, 2022.
The following table presents the contractual maturities of the Company’s short-term investments:
As of October 31, 2022
 
Amortized
Cost
Estimated
Fair Value
(dollars in thousands)
Due within one year$1,925,930 $1,896,477 
Due between one to five years335,941 327,061 
 Total$2,261,871 $2,223,538 
Interest receivable of $8.9 million and $6.0 million is included in Prepaid expenses and other current assets on the condensed consolidated balance sheets as of October 31, 2022 and January 31, 2022, respectively.
The following table presents the fair values and unrealized losses related to the Company’s investments in available-for-sale debt securities classified by length of time that the securities have been in a continuous unrealized loss position as of October 31, 2022:

 Less Than 12 MonthsMore Than 12 MonthsTotal
 
Estimated Fair Value
Unrealized
Losses
Estimated Fair Value
Unrealized
Losses
Estimated Fair Value
Unrealized
Losses
(dollars in thousands)
U.S. treasury securities$1,129,711 $(19,305)$867,829 $(15,535)$1,997,540 $(34,840)
Corporate debt securities66,040 (1,035)159,958 (2,458)225,998 (3,493)
Total$1,195,751 $(20,340)$1,027,787 $(17,993)$2,223,538 $(38,333)
The Company had 189 and 193 short-term investments in unrealized loss positions as of October 31, 2022 and January 31, 2022, respectively.
For available-for-sale debt securities that have unrealized losses, the Company evaluates whether (i) the Company has the intention to sell any of these investments, (ii) it is not more likely than not that the Company will be required to sell any of these available-for-sale debt securities before recovery of the entire amortized cost basis and (iii) the decline in the fair value of the investment is due to credit or non-credit related factors. Based on this evaluation, the Company determined that for short-term investments, there were no material credit or non-credit related impairments as of October 31, 2022 and January 31, 2022.
Strategic Investments
The Company's strategic investments primarily include equity investments in privately-held companies, which do not have a readily determinable fair value. As of October 31, 2022 and January 31, 2022, the balance of strategic investments was $23.6 million and $15.3 million, respectively.
v3.22.2.2
Fair Value Measurements
 9 Months Ended
Oct. 31, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The Company measures its financial assets at fair value each reporting period using a fair value hierarchy that prioritizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
Three levels of inputs may be used to measure as follows:
Level 1—Valuations based on observable inputs that reflect quoted prices for identical assets or liabilities in active markets.
Level 2—Valuations based on other inputs that are directly or indirectly observable in the marketplace.
Level 3—Valuations based on unobservable inputs that are supported by little or no market activity.
Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following tables present information about the Company’s financial assets that were measured at fair value on a recurring basis using the above input categories:
 As of October 31, 2022
 Level 1
Level 2 
Level 3Total
(dollars in thousands)
Assets:    
Cash equivalents:    
Money market funds$91,598 $— $— $91,598 
Total cash equivalents91,598 — — 91,598 
Short-term investments:    
U.S. treasury securities— 1,997,540 — 1,997,540 
Corporate debt securities— 225,998 — 225,998 
Total short-term investments— 2,223,538 — 2,223,538 
Total cash equivalents and short-term investments$91,598 $2,223,538 $— $2,315,136 
 As of January 31, 2022
 Level 1
Level 2 
Level 3Total
(dollars in thousands)
Assets:    
Cash equivalents:    
Money market funds$152,223 $— $— $152,223 
Total cash equivalents152,223 — — 152,223 
Short-term investments:    
U.S. treasury securities— 1,912,188 — 1,912,188 
Corporate debt securities— 329,469 — 329,469 
Total short-term investments— 2,241,657 — 2,241,657 
Total cash equivalents and short-term investments$152,223 $2,241,657 $— $2,393,880 
The carrying amounts of certain financial instruments, including cash held in banks, accounts receivable and accounts payable, approximate fair value due to their short-term maturities and are excluded from the fair value tables above.
Fair Value Measurements of Other Financial Instruments
The following table presents the principal amounts and estimated fair values of the Company’s financial instruments that are not recorded at fair value on the condensed consolidated balance sheets:
 As of October 31, 2022
 Principal Amount
Estimated
Fair Value 
(dollars in thousands)
2023 convertible senior notes$5,226 $6,001 
2025 convertible senior notes1,059,997 887,747 
2026 convertible senior notes1,150,000 925,635 

The 2023 convertible senior notes (“2023 Notes”), the 2025 convertible senior notes (“2025 Notes”), and the 2026 convertible senior notes (“2026 Notes”, and together with the 2023 Notes and 2025 Notes, the “Notes”) are recorded at face value less unamortized debt issuance costs (See Note 9 for additional details). The estimated fair
values of the Notes, which are Level 2 financial instruments, were determined based on the quoted bid prices of the Notes in an over-the-counter market on the last trading day of the reporting period.
v3.22.2.2
Deferred Commissions
 9 Months Ended
Oct. 31, 2022
Revenue from Contract with Customer [Abstract]  
Deferred Commissions Deferred CommissionsSales commissions capitalized as contract costs totaled $32.5 million and $35.7 million in the three months ended October 31, 2022 and 2021, respectively, and $81.9 million and $90.6 million in the nine months ended October 31, 2022 and 2021, respectively. Amortization of contract costs was $21.3 million and $14.9 million for the three months ended October 31, 2022 and 2021, respectively, and $60.8 million and $40.0 million for the nine months ended October 31, 2022 and 2021, respectively. Deferred Revenue and Performance Obligations
Deferred Revenue
Deferred revenue, which is a contract liability, consists primarily of payments received and accounts receivable recorded in advance of revenue recognition under the Company’s contracts with customers and is recognized as the revenue recognition criteria are met.
Subscription revenue recognized during the three months ended October 31, 2022 and 2021 that was included in the deferred revenue balances at the beginning of the respective periods was $417.8 million and $299.9 million, respectively, and $858.0 million and $459.4 million in the nine months ended October 31, 2022 and 2021, respectively. Professional services and other revenue recognized during the three months ended October 31, 2022 and 2021 that was included in the deferred revenue balances at the beginning of the respective periods was $5.9 million and $4.5 million, respectively, and $12.9 million and $5.9 million in the nine months ended October 31, 2022 and 2021, respectively.
Transaction Price Allocated to the Remaining Performance Obligations
Transaction price allocated to the remaining performance obligations (“RPO”) represents all future, non-cancelable contracted revenue that has not yet been recognized, inclusive of deferred revenue that has been invoiced and non-cancelable amounts that will be invoiced and recognized as revenue in future periods.
As of October 31, 2022, total remaining non-cancelable performance obligations under the Company’s subscription contracts with customers was approximately $2,852.8 million. Of this amount, the Company expects to recognize revenue of approximately $1,579.4 million, or 55%, over the next 12 months, with the balance to be recognized as revenue thereafter. Remaining performance obligations for professional services and other contracts as of October 31, 2022 were not material.
v3.22.2.2
Goodwill and Intangible Assets, net
 9 Months Ended
Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets, net Goodwill and Intangible Assets, net
Goodwill
As of October 31, 2022 and January 31, 2022, goodwill was $5,400.3 million and $5,401.3 million, respectively. No goodwill impairments were recorded during the three and nine months ended October 31, 2022 and 2021.
Intangible Assets, net
Intangible assets consisted of the following:
 As of October 31, 2022
GrossAccumulated AmortizationNet
(dollars in thousands)
Capitalized internal-use software costs$48,016 $(28,607)$19,409 
Purchased developed technology219,800 (81,187)138,613 
Customer relationships140,900 (52,798)88,102 
Trade name21,400 (6,420)14,980 
Software licenses1,797 (1,076)721 
 $431,913 $(170,088)$261,825 
 As of January 31, 2022
GrossAccumulated AmortizationNet
(dollars in thousands)
Capitalized internal-use software costs$36,319 $(24,170)$12,149 
Purchased developed technology219,100 (47,085)172,015 
Customer relationships140,900 (26,399)114,501 
Trade name21,400 (3,210)18,190 
Software licenses116 (3)113 
 $417,835 $(100,867)$316,968 
The weighted-average remaining useful lives of the Company’s acquired intangible assets are as follows:
 Weighted-Average Remaining Useful Life
As of October 31, 2022As of January 31, 2022
Purchased developed technology3.3 years4.0 years
Customer relationships3.5 years4.0 years
Trade name3.5 years4.3 years
Amortization expense of intangible assets for the three months ended October 31, 2022 and 2021 was $23.3 million and $22.4 million, respectively, and $69.2 million and $46.6 million for the nine months ended October 31, 2022 and 2021, respectively.
v3.22.2.2
Deferred Revenue and Performance Obligations
 9 Months Ended
Oct. 31, 2022
Revenue from Contract with Customer [Abstract]  
Deferred Revenue and Performance Obligations Deferred CommissionsSales commissions capitalized as contract costs totaled $32.5 million and $35.7 million in the three months ended October 31, 2022 and 2021, respectively, and $81.9 million and $90.6 million in the nine months ended October 31, 2022 and 2021, respectively. Amortization of contract costs was $21.3 million and $14.9 million for the three months ended October 31, 2022 and 2021, respectively, and $60.8 million and $40.0 million for the nine months ended October 31, 2022 and 2021, respectively. Deferred Revenue and Performance Obligations
Deferred Revenue
Deferred revenue, which is a contract liability, consists primarily of payments received and accounts receivable recorded in advance of revenue recognition under the Company’s contracts with customers and is recognized as the revenue recognition criteria are met.
Subscription revenue recognized during the three months ended October 31, 2022 and 2021 that was included in the deferred revenue balances at the beginning of the respective periods was $417.8 million and $299.9 million, respectively, and $858.0 million and $459.4 million in the nine months ended October 31, 2022 and 2021, respectively. Professional services and other revenue recognized during the three months ended October 31, 2022 and 2021 that was included in the deferred revenue balances at the beginning of the respective periods was $5.9 million and $4.5 million, respectively, and $12.9 million and $5.9 million in the nine months ended October 31, 2022 and 2021, respectively.
Transaction Price Allocated to the Remaining Performance Obligations
Transaction price allocated to the remaining performance obligations (“RPO”) represents all future, non-cancelable contracted revenue that has not yet been recognized, inclusive of deferred revenue that has been invoiced and non-cancelable amounts that will be invoiced and recognized as revenue in future periods.
As of October 31, 2022, total remaining non-cancelable performance obligations under the Company’s subscription contracts with customers was approximately $2,852.8 million. Of this amount, the Company expects to recognize revenue of approximately $1,579.4 million, or 55%, over the next 12 months, with the balance to be recognized as revenue thereafter. Remaining performance obligations for professional services and other contracts as of October 31, 2022 were not material.
v3.22.2.2
Convertible Senior Notes, Net
 9 Months Ended
Oct. 31, 2022
Debt Disclosure [Abstract]  
Convertible Senior Notes, Net Convertible Senior Notes, Net
2023 Convertible Senior Notes
The 2023 Notes are senior, unsecured obligations of the Company, and bear interest at a fixed rate of 0.25% per year. Interest is payable in cash semi-annually in arrears on February 15 and August 15 of each year, beginning on August 15, 2018. The 2023 Notes mature on February 15, 2023 unless earlier repurchased or converted. The Company may not redeem the 2023 Notes prior to maturity.
There have been no changes to the terms of the 2023 Notes, Note Hedges (as defined below), or Warrants (as defined below) from those disclosed in the Company’s Form 10-K for the fiscal year ended January 31, 2022.
The 2023 Notes are currently convertible at the option of the holders, in whole or in part, as of October 15, 2022 until the close of business on the second scheduled trading day immediately preceding the maturity date, regardless of the conversion conditions. The 2023 Notes are classified as current liabilities on the condensed consolidated balance sheet as of October 31, 2022.
As of October 31, 2022, $5.2 million of principal remained outstanding on the 2023 Notes. During the three months ended October 31, 2022, the Company did not settle any of the 2023 Notes and during the nine months ended October 31, 2022, the Company issued approximately 0.2 million shares of Class A common stock and paid an immaterial amount in cash to settle approximately $12.0 million principal amount of 2023 Notes.
During the year ended January 31, 2022, the Company issued approximately 0.5 million shares of Class A common stock and paid an immaterial amount in cash to settle approximately $23.0 million principal amount of 2023 Notes.
As of October 31, 2022, the effective interest rate on the 2023 Notes was 0.85%. As of October 31, 2021, prior to the adoption of ASU 2020-06, the effective interest rate on the liability component of the 2023 Notes was 5.68%. The following table sets forth total interest expense recognized related to the 2023 Notes:
Three Months Ended
October 31,		Nine Months Ended
October 31,
2022202120222021
(dollars in thousands)
Contractual interest expense$3 $9 $14 $43 
Amortization of debt issuance costs8 22 35 84 
Amortization of debt discount(1)
— 213 — 837 
Total$11 $244 $49 $964 
(1) Not applicable subsequent to adoption of ASU 2020-06.
The net carrying amount of the 2023 Notes consisted of the following:
As of October 31, 2022As of January 31, 2022
(dollars in thousands)
Liability component:
Principal$5,226 $17,228 
Less: unamortized debt issuance costs and debt discount(1)
(9)(1,034)
Net carrying amount$5,217 $16,194 
As of October 31, 2022As of January 31, 2022
(dollars in thousands)
Equity component:(1)
2023 Notes$— $3,993 
Less: issuance costs— (116)
Carrying amount of the equity component(2)
$— $3,877 
(1) Subsequent to the adoption of ASU 2020-06 under the modified retrospective method, the equity component and debt discount are eliminated.
(2) Included in the January 31, 2022 condensed consolidated balance sheet within Additional paid-in capital.
Note Hedges
In connection with the pricing of the 2023 Notes, the Company entered into convertible note hedges with respect to its Class A common stock (the “Note Hedges”). The Note Hedges are purchased call options that give the Company the option to purchase shares, subject to anti-dilution adjustments substantially identical to those in the 2023 Notes, of its Class A common stock for approximately $48.36 per share (subject to adjustment), corresponding to the approximate initial conversion price of the 2023 Notes, exercisable upon conversion of the 2023 Notes. The Note Hedges will expire in 2023, if not exercised earlier. The Note Hedges are separate transactions and are not part of the terms of the 2023 Notes.
During the three months ended October 31, 2022, the Company did not settle any Note Hedges and during the nine months ended October 31, 2022, the Company exercised and net-share-settled Note Hedges
corresponding to approximately $12.0 million principal amount of 2023 Notes and received approximately 0.1 million shares of Class A common stock and an immaterial cash payment.
As of October 31, 2022, Note Hedges giving the Company the option to purchase approximately 0.1 million shares (subject to adjustment) remained outstanding.
Warrants
In connection with the issuance of the 2023 Notes, the Company entered into separate warrant transactions pursuant to which it sold net-share-settled (or, at the Company’s election subject to certain conditions, cash-settled) warrants (the “Warrants”) to acquire shares, subject to anti-dilution adjustments, over 80 scheduled trading days beginning in May 2023 of the Company’s Class A common stock at an initial exercise price of approximately $68.06 per share (subject to adjustment). The Warrants are separate transactions and are not part of the terms of the 2023 Notes or the Note Hedges.
As of October 31, 2022, Warrants to acquire up to approximately 1.0 million shares (subject to adjustment) remained outstanding.
2025 Convertible Senior Notes
The 2025 Notes are senior, unsecured obligations of the Company, and bear interest at a fixed rate of 0.125% per year. Interest is payable in cash semi-annually in arrears on March 1 and September 1 of each year, beginning on March 1, 2020. The 2025 Notes mature on September 1, 2025 unless earlier redeemed, repurchased or converted.
There have been no changes to the terms of the 2025 Notes or 2025 Capped Calls (as defined below) from those disclosed in the Company’s Form 10-K for the fiscal year ended January 31, 2022.
As of October 31, 2022, the conditions allowing holders of the 2025 Notes to convert were not met, and as a result, the 2025 Notes were classified as noncurrent liabilities on the condensed consolidated balance sheet.
As of October 31, 2022, the effective interest rate on the 2025 Notes was 0.43%. As of October 31, 2021, prior to the adoption of ASU 2020-06, the effective interest rate on the liability component of the 2025 Notes was 4.10%. The following table sets forth total interest expense recognized related to the 2025 Notes:
Three Months Ended
October 31,		Nine Months Ended
October 31,
2022202120222021
(dollars in thousands)
Contractual interest expense$332 $332 $994 $994 
Amortization of debt issuance costs809 581 2,424 1,705 
Amortization of debt discount(1)
— 8,878 — 26,368 
Total$1,141 $9,791 $3,418 $29,067 
(1) Not applicable subsequent to adoption of ASU 2020-06.
The net carrying amount of the 2025 Notes consisted of the following:
As of October 31, 2022As of January 31, 2022
(dollars in thousands)
Liability component:
Principal$1,059,997 $1,059,997 
Less: unamortized debt issuance costs and debt discount(1)
(9,239)(149,333)
Net carrying amount$1,050,758 $910,664 
As of October 31, 2022As of January 31, 2022
(dollars in thousands)
Equity component:(1)
2025 Notes$— $221,387 
Less: issuance costs— (4,040)
Carrying amount of the equity component(2)
$— $217,347 
(1) Subsequent to the adoption of ASU 2020-06 under the modified retrospective method, the equity component and debt discount are eliminated.
(2) Included in the January 31, 2022 condensed consolidated balance sheet within Additional paid-in capital.
2025 Capped Calls
In connection with the pricing of the 2025 Notes, the Company entered into capped call transactions with respect to its Class A common stock (the “2025 Capped Calls”). The 2025 Capped Calls are purchased call options that give the Company the option to purchase approximately 5.6 million shares, subject to anti-dilution adjustments substantially identical to those in the 2025 Notes, of its Class A common stock for approximately $188.71 per share (subject to adjustment), corresponding to the approximate initial conversion price of the 2025 Notes, exercisable upon conversion of the 2025 Notes. The 2025 Capped Calls have initial cap prices of $255.88 per share (subject to adjustment) and will expire in 2025, if not exercised earlier. The 2025 Capped Calls are separate transactions and are not part of the terms of the 2025 Notes.
2026 Convertible Senior Notes
The 2026 Notes are senior, unsecured obligations of the Company, and bear interest at a fixed rate of 0.375% per year. Interest is payable in cash semi-annually in arrears on June 15 and December 15 of each year, beginning on December 15, 2020. The 2026 Notes mature on June 15, 2026 unless earlier redeemed, repurchased or converted.
There have been no changes to the terms of the 2026 Notes or 2026 Capped Calls (as defined below) from those disclosed in the Company’s Form 10-K for the fiscal year ended January 31, 2022.
As of October 31, 2022, the conditions allowing holders of the 2026 Notes to convert were not met, and as a result, the 2026 Notes were classified as noncurrent liabilities on the condensed consolidated balance sheet.
As of October 31, 2022, the effective interest rate on the 2026 Notes was 0.60%. As of October 31, 2021, prior to the adoption of ASU 2020-06, the effective interest rate on the liability component of the 2026 Notes was 5.75%. The following table sets forth total interest expense recognized related to the 2026 Notes:
Three Months Ended
October 31,		Nine Months Ended
October 31,
2022202120222021
(dollars in thousands)
Contractual interest expense$1,078 $1,078 $3,234 $3,234 
Amortization of debt issuance costs628 364 1,881 1,056 
Amortization of debt discount(1)
— 11,640 — 34,428 
Total$1,706 $13,082 $5,115 $38,718 
(1) Not applicable subsequent to adoption of ASU 2020-06.
The net carrying amount of the 2026 Notes consisted of the following:
As of October 31, 2022As of January 31, 2022
(dollars in thousands)
Liability component:
Principal$1,150,000 $1,150,000 
Less: unamortized debt issuance costs and debt discount(1)
(9,211)(244,950)
Net carrying amount$1,140,789 $905,050 
As of October 31, 2022As of January 31, 2022
(dollars in thousands)
Equity component:(1)
2026 Notes$— $310,311 
Less: issuance costs— (4,090)
Carrying amount of the equity component(2)
$— $306,221 
(1) Subsequent to the adoption of ASU 2020-06 under the modified retrospective method, the equity component and debt discount are eliminated.
(2) Included in the January 31, 2022 condensed consolidated balance sheet within Additional paid-in capital.
2026 Capped Calls
In connection with the pricing of the 2026 Notes, the Company entered into capped call transactions with respect to its Class A common stock (the “2026 Capped Calls”). The 2026 Capped Calls are purchased call options that give the Company the option to purchase approximately 4.8 million shares, subject to anti-dilution adjustments substantially identical to those in the 2026 Notes, of its Class A common stock for approximately $238.60 per share (subject to adjustment), corresponding to the approximate initial conversion price of the 2026 Notes, exercisable upon conversion of the 2026 Notes. The 2026 Capped Calls have initial cap prices of $360.14 per share (subject to adjustment) and will expire in 2026, if not exercised earlier. The 2026 Capped Calls are separate transactions and are not part of the terms of the 2026 Notes.
v3.22.2.2
Leases
 9 Months Ended
Oct. 31, 2022
Leases [Abstract]  
Leases LeasesThe Company has entered into various non-cancelable office space operating leases with original lease periods expiring between 2022 and 2029. These leases do not contain material variable rent payments, residual value guarantees, financial covenants or other restrictions.
Operating lease costs were as follows:
Three Months Ended
October 31,		Nine Months Ended
October 31,
2022202120222021
(dollars in thousands)
Operating lease cost(1)
$10,218 $9,677 $30,954 $28,135 
(1) Amounts are presented exclusive of sublease income and include leases with an original term of 12 months or less (short-term leases), which are immaterial.
The weighted-average remaining term of the Company’s operating leases was 5.3 years and 5.9 years as of October 31, 2022 and January 31, 2022, respectively, and the weighted-average discount rate used to measure the present value of the operating lease liabilities was 5.3% and 5.5%, respectively.
Maturities of the Company’s operating lease liabilities, which do not include short-term leases, are as follows:
As of October 31, 2022
Fiscal Year Ending January 31:(dollars in thousands)
2023 (remaining three months)$11,367 
202444,971 
202541,540 
202631,309 
202730,500 
Thereafter53,608 
Total lease payments213,295 
Less imputed interest(27,876)
Less tenant improvement allowances not yet recognized(1,979)
Total operating lease liabilities$183,440 
Cash payments made related to operating lease liabilities were $11.3 million and $10.3 million in the three months ended October 31, 2022 and 2021, respectively, and $29.5 million and $29.4 million in the nine months ended October 31, 2022 and 2021, respectively.
During the three months ended October 31, 2022, the Company announced a real estate optimization plan which provided for closing duplicative sites and decommissioning underutilized offices and floors. As a result, the Company recognized $14.2 million of non-cash lease impairment charges included in general and administrative expenses on the condensed consolidated statement of operations for the three months ended October 31, 2022. The non-cash lease impairment charges represent the amount that the carrying value of the asset groups exceeded their estimated fair values. The asset groups primarily include operating lease right-of-use assets, leasehold improvements, and related property and equipment. To estimate the fair value of the asset group, the Company utilized a discounted cash flow approach using market participant assumptions of the expected cash flows and discount rate.
v3.22.2.2
Commitments and Contingencies
 9 Months Ended
Oct. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Letters of Credit
In conjunction with the execution of certain office space operating leases, letters of credit in the aggregate amount of $8.5 million and $8.6 million were issued and outstanding as of October 31, 2022 and January 31, 2022, respectively. No draws have been made under such letters of credit. Noncurrent restricted cash of $6.3 million and $6.4 million associated with these letters of credit is included in Other assets on the condensed consolidated balance sheets as of October 31, 2022 and January 31, 2022, respectively.
Purchase Obligations
Except as discussed below, there were no significant changes in future minimum purchase obligations as disclosed in the Company’s audited consolidated financial statements for the year ended January 31, 2022.
Effective July 2022, the Company terminated its existing agreement and entered into a new agreement with a cloud services provider with a total obligation of $450.0 million over a four-year period.
Legal Matters
From time to time in the normal course of business, the Company may be subject to various legal matters such as threatened or pending claims or proceedings. There were no such material matters as of October 31, 2022.
Warranties and Indemnification
To date, the Company has not incurred significant costs and has not accrued any material liabilities in the accompanying condensed consolidated financial statements as a result of its warranty and indemnification obligations.
v3.22.2.2
Employee Incentive Plans
 9 Months Ended
Oct. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Employee Incentive Plans Employee Incentive Plans
The Company’s equity incentive plans provide for granting stock options, restricted stock units (“RSUs”), restricted stock awards to employees, consultants, officers and directors and restricted stock units with market-based vesting conditions to certain executives. In addition, the Company offers an Employee Stock Purchase Plan (“ESPP”) to eligible employees.
Stock-based compensation expense was recorded in the following cost and expense categories in the Company’s condensed consolidated statements of operations:
 Three Months Ended
October 31,		Nine Months Ended
October 31,
 2022202120222021
(dollars in thousands)
Cost of revenue    
Subscription$17,106 $13,455 $51,509 $33,843 
Professional services and other3,563 3,376 11,016 8,879 
Research and development69,208 56,573 208,330 129,998 
Sales and marketing41,515 39,248 120,299 101,602 
General and administrative39,593 43,133 120,533 133,289 
Total$170,985 $155,785 $511,687 $407,611 
Equity Incentive Plans
The Company has two equity incentive plans: the 2009 Stock Plan and the 2017 Equity Incentive Plan (“2017 Plan”). In addition, the Company assumed Auth0 equity incentive plans. All shares that remain available for future grants are under the 2017 Plan. As of October 31, 2022, options to purchase 1,841,836 shares of Class A common stock and 4,787,688 shares of Class B common stock remained outstanding.
Shares of common stock reserved for future issuance are as follows:
As of October 31, 2022
Stock options and unvested RSUs outstanding15,807,738 
Available for future stock option and RSU grants26,022,656 
Available for ESPP7,053,433 
 48,883,827 
Stock Options
A summary of the Company’s stock option activity and related information is as follows:
Number of
Options 
Weighted-
Average
Exercise
Price 
Weighted-
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic 
Value
(in thousands)
Outstanding as of January 31, 20227,984,078 $39.59 5.2$1,314,031 
Granted— — 
Exercised(1,177,880)12.41 
Expired(24,833)195.71 
Forfeited(151,841)62.73 
Outstanding as of October 31, 20226,629,524 $43.30 4.6$249,207 
As of October 31, 2022
Vested and exercisable5,855,640 $27.07 4.1$242,916 
As of October 31, 2022, there was a total of $112.5 million of unrecognized stock-based compensation expense related to options, which is being recognized over a weighted-average period of 1.9 years.
Restricted Stock Units
A summary of the Company’s RSU activity (inclusive of market-based RSUs) and related information is as follows:
Number of
RSUs		Weighted-
Average
Grant Date Fair Value Per Share
Outstanding as of January 31, 20226,225,747 $207.26 
Granted6,087,249 121.08 
Vested(1,956,194)177.54 
Forfeited(1,178,588)195.91 
Outstanding as of October 31, 20229,178,214 $157.90 
As of October 31, 2022, there was $1,304.0 million of unrecognized stock-based compensation expense related to unvested RSUs, which is being recognized over a weighted-average period of 3.1 years based on vesting under the award service conditions.
Market-based Restricted Stock Units
In March 2022, the Company granted market-based RSUs to certain members of management. The target number of market-based RSUs granted was 58,150. One-third of these market-based RSUs vest over each of a one-, two- and three-year performance period, each starting on February 1, 2022. The number of shares that can be earned ranges from 0% to 200% of the target number of shares based on the relative performance of the per share price of the Company’s common stock as compared to the Nasdaq Composite Index over the respective performance periods and subject to continuous employment through the vesting dates. The $244.73 grant date fair value per target market-based RSU was determined using a Monte Carlo simulation approach. Compensation expense for awards with market conditions is recognized over the service period using the accelerated attribution method and is not reversed if the market condition is not met.
Restricted Stock Awards Issued in Connection with Business Combinations
In fiscal year 2022, the Company entered into revesting agreements with the founders of the acquired businesses pursuant to which 1,269,008 restricted shares of Okta’s Class A common stock with a weighted-average fair value per share of $268.98 issued as of the respective closing dates will vest over 3 years.

In connection with the business combinations, as of October 31, 2022, there was $172.4 million of unrecognized stock-based compensation expense related to unvested restricted shares, which is being recognized over a weighted-average period of 1.5 years based on vesting under the award service conditions.
Employee Stock Purchase Plan
The ESPP provides for 12-month offering periods beginning June 21 and December 21 of each year, and each offering period consists of up to two six-month purchase periods. The ESPP contains a reset provision under which the offering period resets if the fair market value of the Company’s common stock on the purchase date is less than the fair market value on the offering date.
The Company estimated the fair value of ESPP purchase rights using a Black-Scholes option pricing model with the following assumptions:
 Three Months Ended
October 31,		Nine Months Ended
October 31,
 2022202120222021
Expected volatility
—%- —%
—% - —%
63% - 78%
47% - 48%
Expected term (in years)
0 - 0
0 - 0
0.5 - 1.0
0.5 - 1.0
Risk-free interest rate
—% - —%
—% - —%
2.46% - 2.92%
0.06% - 0.09%
Expected dividend yield————
During the nine months ended October 31, 2022, the Company’s employees purchased 269,814 shares of its Class A common stock under the ESPP. The shares were purchased at a weighted-average purchase price of $70.27 per share, with total proceeds of $19.0 million.
As of October 31, 2022, there was $15.2 million of unrecognized stock-based compensation expense related to the ESPP that is expected to be recognized over a weighted-average vesting period of 0.6 years.
v3.22.2.2
Income Taxes
 9 Months Ended
Oct. 31, 2022
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
For the three and nine months ended October 31, 2022, the Company recorded a tax provision of $3.7 million and $9.8 million on pretax losses of $205.2 million and $652.3 million, respectively. The effective tax rate for the three and nine months ended October 31, 2022 was approximately (1.8)% and (1.5)%, respectively. The effective tax rate differs from the statutory rate primarily as a result of not recognizing the tax benefit for U.S. losses due to a full valuation allowance against U.S. deferred tax assets, the tax effect of foreign operations, U.S. state taxes, and stock-based compensation shortfalls in the United Kingdom.
The Tax Cuts and Jobs Act enacted on December 22, 2017 amended Internal Revenue Code Section 174 to require that specific research and experimental (“R&E”) expenditures be capitalized and amortized over five years (U.S. R&E) or fifteen years (non-U.S. R&E) beginning in the Company's fiscal 2023. Although Congress has considered legislation that would defer, modify or repeal the capitalization and amortization requirement, to date the provision has not been deferred, repealed or otherwise modified. As a result, the Company may be required to utilize some of its federal and state tax attributes and there may be increases to cash taxes or tax expense.
For the three and nine months ended October 31, 2021, the Company recorded a tax provision of $0.7 million and a tax benefit of $6.8 million on pretax losses of $220.6 million and $614.0 million, respectively. The effective tax rate for the three and nine months ended October 31, 2021 was approximately (0.3)% and 1.1%, respectively. The effective tax rate differs from the statutory rate primarily as a result of not recognizing deferred tax assets for U.S. losses due to a full valuation allowance against U.S. deferred tax assets, release of the valuation allowance in the United States in connection with the acquired businesses, a remeasurement of deferred tax assets in connection with a tax rate change in the United Kingdom, and excess tax benefits from stock-based compensation in the United
Kingdom. The tax benefit for the nine months ended October 31, 2021 was partially offset by income tax expense in profitable foreign jurisdictions and U.S. state taxes.
v3.22.2.2
Net Loss Per Share
 9 Months Ended
Oct. 31, 2022
Earnings Per Share [Abstract]  
Net Loss Per Share Net Loss Per Share
The following table presents the calculation of basic and diluted net loss per share:
 Three Months Ended
October 31,		Nine Months Ended
October 31,
 2022202120222021
 Class A Class BClass A Class BClass A Class BClass A Class B
(dollars in thousands, except per share data)
Numerator: 
Net loss$(199,456)$(9,441)$(211,176)$(10,135)$(632,425)$(29,657)$(576,106)$(31,119)
Denominator:
Weighted-average shares outstanding, basic and diluted151,535 7,173 146,715 7,041 150,296 7,048 138,311 7,471 
Net loss per share, basic and diluted$(1.32)$(1.32)$(1.44)$(1.44)$(4.21)$(4.21)$(4.17)$(4.17)
As the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share as the inclusion of all potential common shares outstanding would have been anti-dilutive. Potentially dilutive securities that are not included in the diluted per share calculations because they would be anti-dilutive are as follows:
As of October 31,
 20222021
(in thousands)
Issued and outstanding stock options6,630 8,621 
Unvested RSUs issued and outstanding9,120 5,221 
Unvested market-based RSUs issued and outstanding116 — 
Unvested restricted stock awards issued and outstanding743 1,269 
Shares committed under the ESPP597 213 
Shares related to the 2023 Notes108 356 
Shares subject to warrants related to the issuance of the 2023 Notes1,048 1,048 
Shares related to the 2025 Notes5,617 5,617 
Shares related to the 2026 Notes4,820 4,820 
 28,799 27,165 
The Company uses the if-converted method for calculating any potential dilutive effect of the conversion options embedded in the Notes on diluted net income per share, if applicable. The conversion options of the 2023 Notes, 2025 Notes and 2026 Notes are dilutive in periods of net income on a weighted-average basis using an assumed conversion date equal to the later of the beginning of the reporting period and the date of issuance of the respective Notes. The exercise rights of the Warrants will have a dilutive impact on net income per share of common stock under the treasury-stock method when the average market price per share of the Company’s Class A common stock for a given period exceeds the conversion price of $68.06 per share.
v3.22.2.2
Accounting Standards and Significant Accounting Policies (Policies)
 9 Months Ended
Oct. 31, 2022
Accounting Policies [Abstract]  
Basis of Presentation The accompanying unaudited condensed consolidated financial statements, which include the accounts of the Company and its wholly owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim periods. Accordingly, they do not include all of the financial information and footnotes required by GAAP for complete financial statements.
Principles of Consolidation All intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated balance sheet as of January 31, 2022, included herein, was derived from the audited financial statements as of that date. In the opinion of the Company’s management, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary for a fair statement of the results of operations for the interim periods presented but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year ending January 31, 2023 or any future period.
Fiscal Period The Company’s fiscal year ends on January 31. References to fiscal 2023, for example, refer to the fiscal year ending January 31, 2023.
Reclassification Certain reclassifications of components of prior period investing cash flows have been made in the condensed consolidated statements of cash flows to conform to the current period presentation. These reclassifications had no impact on the aggregate cash flow classifications as previously reported.
Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on other assumptions that its management believes are reasonable under the circumstances. Actual results could vary from those estimates. The Company’s most significant estimates include the stand-alone selling price (“SSP”) for each distinct performance obligation included in customer contracts with multiple performance obligations, the determination of the period of benefit for deferred commissions, the determination of the incremental borrowing rate used for operating lease liabilities, the valuation of deferred income tax assets, the valuation of goodwill and acquired intangible assets and their useful lives and the valuation of certain equity awards assumed.
Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted
Recently Adopted Accounting Pronouncements
ASU No. 2020-06
The Company adopted the FASB issued ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), effective February 1, 2022, using the modified retrospective method. The prior period condensed consolidated financial statements have not been retrospectively adjusted and continue to be reported under the accounting standards in effect for those periods.
ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity’s own equity. Among other changes, ASU 2020-06 removes from GAAP the liability and equity separation model for convertible instruments with a cash conversion feature, and as a result, after adoption, no longer requires separately presenting in equity an embedded conversion feature for such debt. Similarly, the embedded conversion feature is no longer amortized into income as interest expense over the life of the instrument. Instead, the convertible debt instrument is accounted for wholly as debt unless (1) a convertible instrument contains features that require bifurcation as a derivative, or (2) a convertible debt instrument was issued at a substantial premium. Additionally, ASU 2020-06 requires the application of the if-converted method to calculate the impact of convertible instruments on diluted earnings per share, which is consistent with the Company’s accounting treatment prior to the adoption of ASU 2020-06.
The Company recognized a cumulative effect of initially applying the ASU as an adjustment to the February 1, 2022 opening balance of accumulated deficit. Due to the elimination of the equity conversion component of the Company’s convertible senior notes outstanding as of February 1, 2022, additional paid-in capital was reduced. The elimination of the equity conversion component had the effect of increasing the Company’s net debt balance. The reduction of other liabilities is related to changes to the Company’s deferred tax liabilities.
ASU No. 2021-08
The Company adopted the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU 2021-08”), effective February 1, 2022, on a prospective basis. The update requires contract assets and contract liabilities acquired in a business combination be recognized and measured in accordance with ASC Topic 606, Revenue from Contracts with Customers. The adoption of ASU 2021-08 did not have a material impact on the Company’s condensed consolidated financial statements.
ASU No. 2021-04
The Company adopted the FASB issued ASU No. 2021-04, Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (“ASU 2021-04”), effective February 1, 2022, on a prospective basis. ASU 2021-04 addresses specific guidance related to modifications or exchanges of freestanding equity-classified written call options (such as warrants) by specifying the accounting for various modification scenarios. The adoption of ASU 2021-04 did not have a material impact on the Company’s condensed consolidated financial statements.
v3.22.2.2
Accounting Standards and Significant Accounting Policies (Tables)
 9 Months Ended
Oct. 31, 2022
Accounting Policies [Abstract]  
Schedule of Impact of New Accounting Pronouncements
The adoption of ASU 2020-06 resulted in the following changes to the Company’s condensed consolidated balance sheet as of February 1, 2022:
Balance at
January 31, 2022		Adjustments from Adoption of ASU 2020-06Balance at
February 1, 2022
(dollars in thousands)
Liabilities
Convertible senior notes, net$16,194 $927 $17,121 
Convertible senior notes, net, noncurrent1,815,714 371,527 2,187,241 
Other liabilities, noncurrent31,775 (866)30,909 
Stockholders’ equity
Additional paid-in capital7,749,716 (527,444)7,222,272 
Accumulated deficit(1,815,867)155,856 (1,660,011)
v3.22.2.2
Cash Equivalents and Investments (Tables)
 9 Months Ended
Oct. 31, 2022
Investments, Debt and Equity Securities [Abstract]  
Schedule of Amortized Costs, Unrealized Gains and Losses and Estimated Fair Value of Cash Equivalents and Short-term Investments
The following tables present the amortized cost, unrealized gain (loss) and estimated fair value of cash equivalents and short-term investments:
 As of October 31, 2022
 
Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Estimated
Fair Value 
(dollars in thousands)
Cash equivalents:    
Money market funds$91,598 $— $— $91,598 
Total cash equivalents91,598 — — 91,598 
Short-term investments:    
U.S. treasury securities2,032,380 — (34,840)1,997,540 
Corporate debt securities229,491 — (3,493)225,998 
Total short-term investments2,261,871 — (38,333)2,223,538 
Total$2,353,469 $— $(38,333)$2,315,136 
 As of January 31, 2022
 
Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Estimated
Fair Value 
(dollars in thousands)
Cash equivalents:    
Money market funds$152,223 $— $— $152,223 
Total cash equivalents152,223 — — 152,223 
Short-term investments:   
U.S. treasury securities1,922,344 10 (10,166)1,912,188 
Corporate debt securities331,050 — (1,581)329,469 
Total short-term investments2,253,394 10 (11,747)2,241,657 
Total$2,405,617 $10 $(11,747)$2,393,880 
Schedule of Contractual Maturities of Short-term Investments The following table presents the contractual maturities of the Company’s short-term investments:
As of October 31, 2022
 
Amortized
Cost
Estimated
Fair Value
(dollars in thousands)
Due within one year$1,925,930 $1,896,477 
Due between one to five years335,941 327,061 
 Total$2,261,871 $2,223,538 
Schedule of Unrealized Loss Position and Fair Value of Debt Securities The following table presents the fair values and unrealized losses related to the Company’s investments in available-for-sale debt securities classified by length of time that the securities have been in a continuous unrealized loss position as of October 31, 2022:

 Less Than 12 MonthsMore Than 12 MonthsTotal
 
Estimated Fair Value
Unrealized
Losses
Estimated Fair Value
Unrealized
Losses
Estimated Fair Value
Unrealized
Losses
(dollars in thousands)
U.S. treasury securities$1,129,711 $(19,305)$867,829 $(15,535)$1,997,540 $(34,840)
Corporate debt securities66,040 (1,035)159,958 (2,458)225,998 (3,493)
Total$1,195,751 $(20,340)$1,027,787 $(17,993)$2,223,538 $(38,333)
v3.22.2.2
Fair Value Measurements (Tables)
 9 Months Ended
Oct. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following tables present information about the Company’s financial assets that were measured at fair value on a recurring basis using the above input categories:
 As of October 31, 2022
 Level 1
Level 2 
Level 3Total
(dollars in thousands)
Assets:    
Cash equivalents:    
Money market funds$91,598 $— $— $91,598 
Total cash equivalents91,598 — — 91,598 
Short-term investments:    
U.S. treasury securities— 1,997,540 — 1,997,540 
Corporate debt securities— 225,998 — 225,998 
Total short-term investments— 2,223,538 — 2,223,538 
Total cash equivalents and short-term investments$91,598 $2,223,538 $— $2,315,136 
 As of January 31, 2022
 Level 1
Level 2 
Level 3Total
(dollars in thousands)
Assets:    
Cash equivalents:    
Money market funds$152,223 $— $— $152,223 
Total cash equivalents152,223 — — 152,223 
Short-term investments:    
U.S. treasury securities— 1,912,188 — 1,912,188 
Corporate debt securities— 329,469 — 329,469 
Total short-term investments— 2,241,657 — 2,241,657 
Total cash equivalents and short-term investments$152,223 $2,241,657 $— $2,393,880 
Schedule of Carrying Amounts and Estimated Fair Values of Convertible Note
The following table presents the principal amounts and estimated fair values of the Company’s financial instruments that are not recorded at fair value on the condensed consolidated balance sheets:
 As of October 31, 2022
 Principal Amount
Estimated
Fair Value 
(dollars in thousands)
2023 convertible senior notes$5,226 $6,001 
2025 convertible senior notes1,059,997 887,747 
2026 convertible senior notes1,150,000 925,635 
v3.22.2.2
Goodwill and Intangible Assets, net (Tables)
 9 Months Ended
Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Intangible Assets, net
Intangible assets consisted of the following:
 As of October 31, 2022
GrossAccumulated AmortizationNet
(dollars in thousands)
Capitalized internal-use software costs$48,016 $(28,607)$19,409 
Purchased developed technology219,800 (81,187)138,613 
Customer relationships140,900 (52,798)88,102 
Trade name21,400 (6,420)14,980 
Software licenses1,797 (1,076)721 
 $431,913 $(170,088)$261,825 
 As of January 31, 2022
GrossAccumulated AmortizationNet
(dollars in thousands)
Capitalized internal-use software costs$36,319 $(24,170)$12,149 
Purchased developed technology219,100 (47,085)172,015 
Customer relationships140,900 (26,399)114,501 
Trade name21,400 (3,210)18,190 
Software licenses116 (3)113 
 $417,835 $(100,867)$316,968 
The weighted-average remaining useful lives of the Company’s acquired intangible assets are as follows:
 Weighted-Average Remaining Useful Life
As of October 31, 2022As of January 31, 2022
Purchased developed technology3.3 years4.0 years
Customer relationships3.5 years4.0 years
Trade name3.5 years4.3 years
v3.22.2.2
Convertible Senior Notes, Net (Tables)
 9 Months Ended
Oct. 31, 2022
Debt Disclosure [Abstract]  
Schedule of Interest Expense
As of October 31, 2022, the effective interest rate on the 2023 Notes was 0.85%. As of October 31, 2021, prior to the adoption of ASU 2020-06, the effective interest rate on the liability component of the 2023 Notes was 5.68%. The following table sets forth total interest expense recognized related to the 2023 Notes:
Three Months Ended
October 31,		Nine Months Ended
October 31,
2022202120222021
(dollars in thousands)
Contractual interest expense$3 $9 $14 $43 
Amortization of debt issuance costs8 22 35 84 
Amortization of debt discount(1)
— 213 — 837 
Total$11 $244 $49 $964 
(1) Not applicable subsequent to adoption of ASU 2020-06.
As of October 31, 2022, the effective interest rate on the 2025 Notes was 0.43%. As of October 31, 2021, prior to the adoption of ASU 2020-06, the effective interest rate on the liability component of the 2025 Notes was 4.10%. The following table sets forth total interest expense recognized related to the 2025 Notes:
Three Months Ended
October 31,		Nine Months Ended
October 31,
2022202120222021
(dollars in thousands)
Contractual interest expense$332 $332 $994 $994 
Amortization of debt issuance costs809 581 2,424 1,705 
Amortization of debt discount(1)
— 8,878 — 26,368 
Total$1,141 $9,791 $3,418 $29,067 
(1) Not applicable subsequent to adoption of ASU 2020-06.
As of October 31, 2022, the effective interest rate on the 2026 Notes was 0.60%. As of October 31, 2021, prior to the adoption of ASU 2020-06, the effective interest rate on the liability component of the 2026 Notes was 5.75%. The following table sets forth total interest expense recognized related to the 2026 Notes:
Three Months Ended
October 31,		Nine Months Ended
October 31,
2022202120222021
(dollars in thousands)
Contractual interest expense$1,078 $1,078 $3,234 $3,234 
Amortization of debt issuance costs628 364 1,881 1,056 
Amortization of debt discount(1)
— 11,640 — 34,428 
Total$1,706 $13,082 $5,115 $38,718 
(1) Not applicable subsequent to adoption of ASU 2020-06.
Schedule of Liability and Equity Component of Notes
The net carrying amount of the 2023 Notes consisted of the following:
As of October 31, 2022As of January 31, 2022
(dollars in thousands)
Liability component:
Principal$5,226 $17,228 
Less: unamortized debt issuance costs and debt discount(1)
(9)(1,034)
Net carrying amount$5,217 $16,194 
As of October 31, 2022As of January 31, 2022
(dollars in thousands)
Equity component:(1)
2023 Notes$— $3,993 
Less: issuance costs— (116)
Carrying amount of the equity component(2)
$— $3,877 
(1) Subsequent to the adoption of ASU 2020-06 under the modified retrospective method, the equity component and debt discount are eliminated.
(2) Included in the January 31, 2022 condensed consolidated balance sheet within Additional paid-in capital.
The net carrying amount of the 2025 Notes consisted of the following:
As of October 31, 2022As of January 31, 2022
(dollars in thousands)
Liability component:
Principal$1,059,997 $1,059,997 
Less: unamortized debt issuance costs and debt discount(1)
(9,239)(149,333)
Net carrying amount$1,050,758 $910,664 
As of October 31, 2022As of January 31, 2022
(dollars in thousands)
Equity component:(1)
2025 Notes$— $221,387 
Less: issuance costs— (4,040)
Carrying amount of the equity component(2)
$— $217,347 
(1) Subsequent to the adoption of ASU 2020-06 under the modified retrospective method, the equity component and debt discount are eliminated.
(2) Included in the January 31, 2022 condensed consolidated balance sheet within Additional paid-in capital.
The net carrying amount of the 2026 Notes consisted of the following:
As of October 31, 2022As of January 31, 2022
(dollars in thousands)
Liability component:
Principal$1,150,000 $1,150,000 
Less: unamortized debt issuance costs and debt discount(1)
(9,211)(244,950)
Net carrying amount$1,140,789 $905,050 
As of October 31, 2022As of January 31, 2022
(dollars in thousands)
Equity component:(1)
2026 Notes$— $310,311 
Less: issuance costs— (4,090)
Carrying amount of the equity component(2)
$— $306,221 
(1) Subsequent to the adoption of ASU 2020-06 under the modified retrospective method, the equity component and debt discount are eliminated.
(2) Included in the January 31, 2022 condensed consolidated balance sheet within Additional paid-in capital.
v3.22.2.2
Leases (Tables)
 9 Months Ended
Oct. 31, 2022
Leases [Abstract]  
Schedule of Operating Lease Costs
Operating lease costs were as follows:
Three Months Ended
October 31,		Nine Months Ended
October 31,
2022202120222021
(dollars in thousands)
Operating lease cost(1)
$10,218 $9,677 $30,954 $28,135 
(1) Amounts are presented exclusive of sublease income and include leases with an original term of 12 months or less (short-term leases), which are immaterial.
Schedule of Maturities of Operating Leases Maturities of the Company’s operating lease liabilities, which do not include short-term leases, are as follows:
As of October 31, 2022
Fiscal Year Ending January 31:(dollars in thousands)
2023 (remaining three months)$11,367 
202444,971 
202541,540 
202631,309 
202730,500 
Thereafter53,608 
Total lease payments213,295 
Less imputed interest(27,876)
Less tenant improvement allowances not yet recognized(1,979)
Total operating lease liabilities$183,440 
v3.22.2.2
Employee Incentive Plans (Tables)
 9 Months Ended
Oct. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense by Statement of Operations Location
Stock-based compensation expense was recorded in the following cost and expense categories in the Company’s condensed consolidated statements of operations:
 Three Months Ended
October 31,		Nine Months Ended
October 31,
 2022202120222021
(dollars in thousands)
Cost of revenue    
Subscription$17,106 $13,455 $51,509 $33,843 
Professional services and other3,563 3,376 11,016 8,879 
Research and development69,208 56,573 208,330 129,998 
Sales and marketing41,515 39,248 120,299 101,602 
General and administrative39,593 43,133 120,533 133,289 
Total$170,985 $155,785 $511,687 $407,611 
Schedule of Shares of Common Stock Reserved for Future Issuance Shares of common stock reserved for future issuance are as follows:
As of October 31, 2022
Stock options and unvested RSUs outstanding15,807,738 
Available for future stock option and RSU grants26,022,656 
Available for ESPP7,053,433 
 48,883,827 
Schedule of Stock Option Activity
A summary of the Company’s stock option activity and related information is as follows:
Number of
Options 
Weighted-
Average
Exercise
Price 
Weighted-
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic 
Value
(in thousands)
Outstanding as of January 31, 20227,984,078 $39.59 5.2$1,314,031 
Granted— — 
Exercised(1,177,880)12.41 
Expired(24,833)195.71 
Forfeited(151,841)62.73 
Outstanding as of October 31, 20226,629,524 $43.30 4.6$249,207 
As of October 31, 2022
Vested and exercisable5,855,640 $27.07 4.1$242,916 
Schedule of Nonvested Restricted Stock Units Activity
A summary of the Company’s RSU activity (inclusive of market-based RSUs) and related information is as follows:
Number of
RSUs		Weighted-
Average
Grant Date Fair Value Per Share
Outstanding as of January 31, 20226,225,747 $207.26 
Granted6,087,249 121.08 
Vested(1,956,194)177.54 
Forfeited(1,178,588)195.91 
Outstanding as of October 31, 20229,178,214 $157.90 
Schedule of ESPP Black-Scholes Option Pricing Model Estimated Fair Value Assumptions The Company estimated the fair value of ESPP purchase rights using a Black-Scholes option pricing model with the following assumptions:
 Three Months Ended
October 31,		Nine Months Ended
October 31,
 2022202120222021
Expected volatility
—%- —%
—% - —%
63% - 78%
47% - 48%
Expected term (in years)
0 - 0
0 - 0
0.5 - 1.0
0.5 - 1.0
Risk-free interest rate
—% - —%
—% - —%
2.46% - 2.92%
0.06% - 0.09%
Expected dividend yield————
v3.22.2.2
Net Loss Per Share (Tables)
 9 Months Ended
Oct. 31, 2022
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Net Loss Per Share
The following table presents the calculation of basic and diluted net loss per share:
 Three Months Ended
October 31,		Nine Months Ended
October 31,
 2022202120222021
 Class A Class BClass A Class BClass A Class BClass A Class B
(dollars in thousands, except per share data)
Numerator: 
Net loss$(199,456)$(9,441)$(211,176)$(10,135)$(632,425)$(29,657)$(576,106)$(31,119)
Denominator:
Weighted-average shares outstanding, basic and diluted151,535 7,173 146,715 7,041 150,296 7,048 138,311 7,471 
Net loss per share, basic and diluted$(1.32)$(1.32)$(1.44)$(1.44)$(4.21)$(4.21)$(4.17)$(4.17)
Schedule of Potentially Dilutive Securities Excluded from Diluted Per Share Calculation Potentially dilutive securities that are not included in the diluted per share calculations because they would be anti-dilutive are as follows:
As of October 31,
 20222021
(in thousands)
Issued and outstanding stock options6,630 8,621 
Unvested RSUs issued and outstanding9,120 5,221 
Unvested market-based RSUs issued and outstanding116 — 
Unvested restricted stock awards issued and outstanding743 1,269 
Shares committed under the ESPP597 213 
Shares related to the 2023 Notes108 356 
Shares subject to warrants related to the issuance of the 2023 Notes1,048 1,048 
Shares related to the 2025 Notes5,617 5,617 
Shares related to the 2026 Notes4,820 4,820 
 28,799 27,165 
v3.22.2.2
Accounting Standards and Significant Accounting Policies (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Oct. 31, 2022
Oct. 31, 2021
Jan. 31, 2022
Liabilities          
Convertible senior notes, net $ 5,217   $ 5,217   $ 16,194
Convertible senior notes, net, noncurrent 2,191,547   2,191,547   1,815,714
Other liabilities, noncurrent 18,392   18,392   31,775
Stockholders’ equity:          
Additional paid-in capital 7,785,753   7,785,753   7,749,716
Accumulated deficit (2,322,093)   (2,322,093)   (1,815,867)
Interest expense decrease $ (2,805) $ (23,144) $ (8,588) $ (68,776)  
Net loss per share, basic, decrease (in dollars per share) $ 1.32 $ 1.44 $ 4.21 $ 4.17  
Net loss per share, diluted, decrease (in dollars per share) $ 1.32 $ 1.44 $ 4.21 $ 4.17  
Adjustment          
Liabilities          
Convertible senior notes, net         927
Convertible senior notes, net, noncurrent         371,527
Other liabilities, noncurrent         (866)
Stockholders’ equity:          
Additional paid-in capital         (527,444)
Accumulated deficit         155,856
Interest expense decrease $ 21,200   $ 63,000    
Net loss per share, basic, decrease (in dollars per share) $ 0.13   $ 0.40    
Net loss per share, diluted, decrease (in dollars per share) $ 0.13   $ 0.40    
Cumulative Effect, Period of Adoption, Adjusted Balance          
Liabilities          
Convertible senior notes, net         17,121
Convertible senior notes, net, noncurrent         2,187,241
Other liabilities, noncurrent         30,909
Stockholders’ equity:          
Additional paid-in capital         7,222,272
Accumulated deficit         $ (1,660,011)
v3.22.2.2
Business Combinations (Details) - USD ($)
$ in Thousands, shares in Millions
 9 Months Ended
Aug. 02, 2021
May 03, 2021
Oct. 31, 2021
Oct. 31, 2022
Jan. 31, 2022
Business Acquisition [Line Items]          
Goodwill       $ 5,400,275 $ 5,401,343
Auth0          
Business Acquisition [Line Items]          
Consideration transferred   $ 5,671,000      
Equity consideration (in shares)   19.2      
Cash consideration   $ 257,000      
Cash consideration held back   $ 3,800      
Equity consideration held back (in shares)   1.1      
Equity consideration held back   $ 294,600      
Acquisition related costs     $ 29,000    
Goodwill   5,290,100      
Auth0 | Common stock          
Business Acquisition [Line Items]          
Equity consideration   5,175,600      
Auth0 | Stock options          
Business Acquisition [Line Items]          
Equity consideration   $ 238,400      
atSpoke          
Business Acquisition [Line Items]          
Consideration transferred $ 79,300        
Cash consideration held back 13,400        
Acquisition related costs     $ 900    
Goodwill $ 62,200        
Cash consideration hold back period 18 months        
atSpoke | Purchased developed technology          
Business Acquisition [Line Items]          
Intangible assets acquired $ 18,300        
Useful life of acquired intangible assets 3 years        
v3.22.2.2
Cash Equivalents and Investments - Schedule of Amortized Costs, Unrealized Gains and Losses and Estimated Fair Value of Cash Equivalents and Short-term Investments (Details) - USD ($)
$ in Thousands
Oct. 31, 2022
Jan. 31, 2022
Cash and Cash Equivalents [Line Items]    
Amortized Cost $ 2,353,469 $ 2,405,617
Unrealized Gain 0 10
Unrealized Loss (38,333) (11,747)
Estimated Fair Value  2,315,136 2,393,880
Cash Equivalents    
Cash and Cash Equivalents [Line Items]    
Amortized Cost 91,598 152,223
Unrealized Gain 0 0
Unrealized Loss 0 0
Estimated Fair Value  91,598 152,223
Cash Equivalents | Money market funds    
Cash and Cash Equivalents [Line Items]    
Amortized Cost 91,598 152,223
Unrealized Gain 0 0
Unrealized Loss 0 0
Estimated Fair Value  91,598 152,223
Short-term Investments    
Cash and Cash Equivalents [Line Items]    
Amortized Cost 2,261,871 2,253,394
Unrealized Gain 0 10
Unrealized Loss (38,333) (11,747)
Estimated Fair Value  2,223,538 2,241,657
Short-term Investments | U.S. treasury securities    
Cash and Cash Equivalents [Line Items]    
Amortized Cost 2,032,380 1,922,344
Unrealized Gain 0 10
Unrealized Loss (34,840) (10,166)
Estimated Fair Value  1,997,540 1,912,188
Short-term Investments | Corporate debt securities    
Cash and Cash Equivalents [Line Items]    
Amortized Cost 229,491 331,050
Unrealized Gain 0 0
Unrealized Loss (3,493) (1,581)
Estimated Fair Value  $ 225,998 $ 329,469
v3.22.2.2
Cash Equivalents and Investments - Schedule of Contractual Maturities of Short-term Investments (Details) - USD ($)
$ in Thousands
Oct. 31, 2022
Jan. 31, 2022
Amortized Cost    
Amortized Cost $ 2,353,469 $ 2,405,617
Estimated Fair Value    
Estimated fair value 2,315,136 2,393,880
Short-term Investments    
Amortized Cost    
Amortized cost, due within one year 1,925,930  
Amortized cost, due between one to five years 335,941  
Amortized Cost 2,261,871 2,253,394
Estimated Fair Value    
Estimated fair value, due within one year 1,896,477  
Estimated fair value, due between one to five years 327,061  
Estimated fair value $ 2,223,538 $ 2,241,657
v3.22.2.2
Cash Equivalents and Investments - Narrative (Details)
 9 Months Ended 12 Months Ended
Oct. 31, 2022
USD ($)
investment
Jan. 31, 2022
USD ($)
investment
Investments, Debt and Equity Securities [Abstract]    
Interest receivable $ 8,900,000 $ 6,000,000
Number of short-term investments in unrealized loss positions (in investments) | investment 189 193
Other-than-temporary impairment short term investment $ 0 $ 0
Strategic investments without a readily determinable fair value $ 23,600,000 $ 15,300,000
v3.22.2.2
Cash Equivalents and Investments - Schedule of Unrealized Loss Position and Fair Value of Debt Securities (Details)
$ in Thousands
Oct. 31, 2022
USD ($)
Schedule of Investments [Line Items]  
Estimated Fair Value, Less Than 12 Months $ 1,195,751
Unrealized Losses, Less Than 12 Months (20,340)
Estimated Fair Value, More Than 12 Months 1,027,787
Unrealized Losses, More Than 12 Months (17,993)
Estimated Fair Value 2,223,538
Unrealized Losses (38,333)
U.S. treasury securities  
Schedule of Investments [Line Items]  
Estimated Fair Value, Less Than 12 Months 1,129,711
Unrealized Losses, Less Than 12 Months (19,305)
Estimated Fair Value, More Than 12 Months 867,829
Unrealized Losses, More Than 12 Months (15,535)
Estimated Fair Value 1,997,540
Unrealized Losses (34,840)
Corporate debt securities  
Schedule of Investments [Line Items]  
Estimated Fair Value, Less Than 12 Months 66,040
Unrealized Losses, Less Than 12 Months (1,035)
Estimated Fair Value, More Than 12 Months 159,958
Unrealized Losses, More Than 12 Months (2,458)
Estimated Fair Value 225,998
Unrealized Losses $ (3,493)
v3.22.2.2
Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - Recurring - USD ($)
$ in Thousands
Oct. 31, 2022
Jan. 31, 2022
Assets:    
Cash equivalents, fair value $ 91,598 $ 152,223
Short term investments, fair value 2,223,538 2,241,657
Total cash equivalents and short-term investments 2,315,136 2,393,880
U.S. treasury securities    
Assets:    
Short term investments, fair value 1,997,540 1,912,188
Corporate debt securities    
Assets:    
Short term investments, fair value 225,998 329,469
Money market funds    
Assets:    
Cash equivalents, fair value 91,598 152,223
Level 1    
Assets:    
Cash equivalents, fair value 91,598 152,223
Short term investments, fair value 0 0
Total cash equivalents and short-term investments 91,598 152,223
Level 1 | U.S. treasury securities    
Assets:    
Short term investments, fair value 0 0
Level 1 | Corporate debt securities    
Assets:    
Short term investments, fair value 0 0
Level 1 | Money market funds    
Assets:    
Cash equivalents, fair value 91,598 152,223
Level 2     
Assets:    
Cash equivalents, fair value 0 0
Short term investments, fair value 2,223,538 2,241,657
Total cash equivalents and short-term investments 2,223,538 2,241,657
Level 2  | U.S. treasury securities    
Assets:    
Short term investments, fair value 1,997,540 1,912,188
Level 2  | Corporate debt securities    
Assets:    
Short term investments, fair value 225,998 329,469
Level 2  | Money market funds    
Assets:    
Cash equivalents, fair value 0 0
Level 3    
Assets:    
Cash equivalents, fair value 0 0
Short term investments, fair value 0 0
Total cash equivalents and short-term investments 0 0
Level 3 | U.S. treasury securities    
Assets:    
Short term investments, fair value 0 0
Level 3 | Corporate debt securities    
Assets:    
Short term investments, fair value 0 0
Level 3 | Money market funds    
Assets:    
Cash equivalents, fair value $ 0 $ 0
v3.22.2.2
Fair Value Measurements - Schedule of Carrying Amounts and Estimated Fair Values of Convertible Note (Details) - Senior Notes
$ in Thousands
Oct. 31, 2022
USD ($)
Net Carrying Amount | 2023 convertible senior notes  
Debt Instrument [Line Items]  
Convertible senior notes $ 5,226
Net Carrying Amount | 2025 convertible senior notes  
Debt Instrument [Line Items]  
Convertible senior notes 1,059,997
Net Carrying Amount | 2026 convertible senior notes  
Debt Instrument [Line Items]  
Convertible senior notes 1,150,000
Estimated Fair Value | 2023 convertible senior notes  
Debt Instrument [Line Items]  
Convertible senior notes 6,001
Estimated Fair Value | 2025 convertible senior notes  
Debt Instrument [Line Items]  
Convertible senior notes 887,747
Estimated Fair Value | 2026 convertible senior notes  
Debt Instrument [Line Items]  
Convertible senior notes $ 925,635
v3.22.2.2
Deferred Commissions (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Oct. 31, 2022
Oct. 31, 2021
Revenue from Contract with Customer [Abstract]        
Sales commissions capitalized as contract costs $ 32.5 $ 35.7 $ 81.9 $ 90.6
Amortization of contract costs $ 21.3 $ 14.9 $ 60.8 $ 40.0
v3.22.2.2
Goodwill and Intangible Assets, net - Narrative (Details) - USD ($)
 3 Months Ended 9 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Oct. 31, 2022
Oct. 31, 2021
Jan. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]          
Goodwill $ 5,400,275,000   $ 5,400,275,000   $ 5,401,343,000
Goodwill impairments 0 $ 0 0 $ 0  
Intangible amortization expense $ 23,300,000 $ 22,400,000 $ 69,200,000 $ 46,600,000  
v3.22.2.2
Goodwill and Intangible Assets, net - Schedule of Intangible Assets (Details) - USD ($)
$ in Thousands
 9 Months Ended 12 Months Ended
Oct. 31, 2022
Jan. 31, 2022
Finite-Lived Intangible Assets [Line Items]    
Gross $ 431,913 $ 417,835
Accumulated Amortization (170,088) (100,867)
Net 261,825 316,968
Capitalized internal-use software costs    
Finite-Lived Intangible Assets [Line Items]    
Gross 48,016 36,319
Accumulated Amortization (28,607) (24,170)
Net 19,409 12,149
Purchased developed technology    
Finite-Lived Intangible Assets [Line Items]    
Gross 219,800 219,100
Accumulated Amortization (81,187) (47,085)
Net $ 138,613 $ 172,015
Weighted-Average Remaining Useful Life 3 years 3 months 18 days 4 years
Customer relationships    
Finite-Lived Intangible Assets [Line Items]    
Gross $ 140,900 $ 140,900
Accumulated Amortization (52,798) (26,399)
Net $ 88,102 $ 114,501
Weighted-Average Remaining Useful Life 3 years 6 months 4 years
Trade name    
Finite-Lived Intangible Assets [Line Items]    
Gross $ 21,400 $ 21,400
Accumulated Amortization (6,420) (3,210)
Net $ 14,980 $ 18,190
Weighted-Average Remaining Useful Life 3 years 6 months 4 years 3 months 18 days
Software licenses    
Finite-Lived Intangible Assets [Line Items]    
Gross $ 1,797 $ 116
Accumulated Amortization (1,076) (3)
Net $ 721 $ 113
v3.22.2.2
Deferred Revenue and Performance Obligations (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Oct. 31, 2022
Oct. 31, 2021
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]        
Revenue from remaining performance obligations $ 2,852.8   $ 2,852.8  
Subscription        
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]        
Revenue recognized that was included in the contract liability balance 417.8 $ 299.9 858.0 $ 459.4
Professional services and other        
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]        
Revenue recognized that was included in the contract liability balance 5.9 $ 4.5 12.9 $ 5.9
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-11-01        
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]        
Revenue from remaining performance obligations $ 1,579.4   $ 1,579.4  
Remaining performance obligation, percentage 55.00%   55.00%  
Performance obligations expected to be satisfied, expected timing 12 months   12 months  
v3.22.2.2
Convertible Senior Notes, Net - Narrative (Details)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Oct. 31, 2022
USD ($)
tradingDay
$ / shares
shares
Oct. 31, 2022
USD ($)
$ / shares
shares
Oct. 31, 2021
shares
Jan. 31, 2022
USD ($)
shares
Aug. 15, 2018
Debt Instrument [Line Items]          
Antidilutive securities excluded from computation of earnings per share (in shares)   28,799 27,165    
2023 convertible senior notes          
Debt Instrument [Line Items]          
Number of shares available for purchase (in shares) 100 100      
Limitation on sale of common stock due to sale price threshold (in days) | tradingDay 80        
Value of shares issuable under warrants granted (in dollars per share) | $ / shares $ 68.06 $ 68.06      
Number of warrants issued subject to anti-dilution adjustments (in shares) 1,000 1,000      
2023 convertible senior notes | Shares related to convertible senior notes          
Debt Instrument [Line Items]          
Antidilutive securities excluded from computation of earnings per share (in shares)   108 356    
2025 convertible senior notes          
Debt Instrument [Line Items]          
Initial cap price of capped calls (in dollars per share) | $ / shares   $ 255.88      
2025 convertible senior notes | Shares related to convertible senior notes          
Debt Instrument [Line Items]          
Antidilutive securities excluded from computation of earnings per share (in shares)   5,617 5,617    
2026 convertible senior notes          
Debt Instrument [Line Items]          
Initial cap price of capped calls (in dollars per share) | $ / shares   $ 360.14      
2026 convertible senior notes | Shares related to convertible senior notes          
Debt Instrument [Line Items]          
Antidilutive securities excluded from computation of earnings per share (in shares)   4,820 4,820    
Senior Notes | 2023 convertible senior notes          
Debt Instrument [Line Items]          
Fixed interest rate         0.25%
Aggregate principal amount | $ $ 5,226 $ 5,226   $ 17,228  
Original debt amount | $   $ 12,000   23,000  
Effective interest rate 0.85% 0.85% 5.68%    
Conversion price (in dollars per share) | $ / shares $ 48.36 $ 48.36      
Hedge exercised and net-share-settled, consideration received on transaction | $   $ 12,000      
Senior Notes | 2025 convertible senior notes          
Debt Instrument [Line Items]          
Fixed interest rate 0.125% 0.125%      
Aggregate principal amount | $ $ 1,059,997 $ 1,059,997   1,059,997  
Effective interest rate 0.43% 0.43% 4.10%    
Conversion price (in dollars per share) | $ / shares $ 188.71 $ 188.71      
Senior Notes | 2026 convertible senior notes          
Debt Instrument [Line Items]          
Fixed interest rate 0.375% 0.375%      
Aggregate principal amount | $ $ 1,150,000 $ 1,150,000   $ 1,150,000  
Effective interest rate 0.60% 0.60% 5.75%    
Conversion price (in dollars per share) | $ / shares $ 238.60 $ 238.60      
Class A Common Stock | Senior Notes | 2023 convertible senior notes          
Debt Instrument [Line Items]          
Shares issued during the period   200   500  
Hedge exercised and net-share-settled, consideration received on transaction (in shares)   100      
v3.22.2.2
Convertible Senior Notes, Net - Schedule of Interest Expense (Details) - Senior Notes - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Oct. 31, 2022
Oct. 31, 2021
2023 convertible senior notes        
Debt Instrument [Line Items]        
Contractual interest expense $ 3 $ 9 $ 14 $ 43
Amortization of debt issuance costs 8 22 35 84
Amortization of debt discount   213   837
Total 11 244 49 964
2025 convertible senior notes        
Debt Instrument [Line Items]        
Contractual interest expense 332 332 994 994
Amortization of debt issuance costs 809 581 2,424 1,705
Amortization of debt discount   8,878   26,368
Total 1,141 9,791 3,418 29,067
2026 convertible senior notes        
Debt Instrument [Line Items]        
Contractual interest expense 1,078 1,078 3,234 3,234
Amortization of debt issuance costs 628 364 1,881 1,056
Amortization of debt discount   11,640   34,428
Total $ 1,706 $ 13,082 $ 5,115 $ 38,718
v3.22.2.2
Convertible Senior Notes, Net - Schedule of Liability and Equity Component of Notes (Details) - Senior Notes - USD ($)
$ in Thousands
Oct. 31, 2022
Jan. 31, 2022
2023 convertible senior notes    
Liability component:    
Principal $ 5,226 $ 17,228
Less: unamortized debt issuance costs and debt discount (9) (1,034)
Net carrying amount 5,217 16,194
2025 convertible senior notes    
Liability component:    
Principal 1,059,997 1,059,997
Less: unamortized debt issuance costs and debt discount (9,239) (149,333)
Net carrying amount 1,050,758 910,664
2026 convertible senior notes    
Liability component:    
Principal 1,150,000 1,150,000
Less: unamortized debt issuance costs and debt discount (9,211) (244,950)
Net carrying amount $ 1,140,789 905,050
Additional Paid-in Capital | 2023 convertible senior notes    
Equity component:    
Equity component   3,993
Less: issuance costs   (116)
Carrying amount of the equity component   3,877
Additional Paid-in Capital | 2025 convertible senior notes    
Equity component:    
Equity component   221,387
Less: issuance costs   (4,040)
Carrying amount of the equity component   217,347
Additional Paid-in Capital | 2026 convertible senior notes    
Equity component:    
Equity component   310,311
Less: issuance costs   (4,090)
Carrying amount of the equity component   $ 306,221
v3.22.2.2
Leases - Schedule of Operating Lease Costs (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Oct. 31, 2022
Oct. 31, 2021
Lease cost:        
Operating lease cost $ 10,218 $ 9,677 $ 30,954 $ 28,135
v3.22.2.2
Leases - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Oct. 31, 2022
Oct. 31, 2021
Jan. 31, 2022
Leases [Abstract]          
Weighted average remaining lease term 5 years 3 months 18 days   5 years 3 months 18 days   5 years 10 months 24 days
Weighted average discount rate 5.30%   5.30%   5.50%
Cash payments included in the measurement of operating lease liabilities $ 11,300 $ 10,300 $ 29,500 $ 29,400  
Lease impairment charges $ 14,200   $ 14,461 $ 0  
v3.22.2.2
Leases - Schedule of Maturities of Operating Leases (Details)
$ in Thousands
Oct. 31, 2022
USD ($)
Lessee, Operating Lease, Liability, Payment, Due [Abstract]  
2023 (remaining three months) $ 11,367
2024 44,971
2025 41,540
2026 31,309
2027 30,500
Thereafter 53,608
Total lease payments 213,295
Less imputed interest (27,876)
Less tenant improvement allowances not yet recognized (1,979)
Total operating lease liabilities $ 183,440
v3.22.2.2
Commitments and Contingencies - Narrative (Details) - USD ($)
 1 Months Ended
Jul. 31, 2022
Oct. 31, 2022
Jan. 31, 2022
Other Commitments [Line Items]      
Long-term purchase commitment $ 450,000,000    
Long-term purchase commitment, period 4 years    
Letter of Credit      
Other Commitments [Line Items]      
Letters of credit issued and outstanding   $ 8,500,000 $ 8,600,000
Draws on line of credit   0 0
Restricted cash, noncurrent   $ 6,300,000 $ 6,400,000
v3.22.2.2
Employee Incentive Plans - Schedule of Stock-based Compensation Expense by Statement of Operations Location (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Oct. 31, 2022
Oct. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense $ 170,985 $ 155,785 $ 511,687 $ 407,611
Subscription        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense 17,106 13,455 51,509 33,843
Professional services and other        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense 3,563 3,376 11,016 8,879
Research and development        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense 69,208 56,573 208,330 129,998
Sales and marketing        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense 41,515 39,248 120,299 101,602
General and administrative        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense $ 39,593 $ 43,133 $ 120,533 $ 133,289
v3.22.2.2
Employee Incentive Plans - Narrative (Details)
$ / shares in Units, $ in Millions
 1 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2022
$ / shares
shares
Oct. 31, 2022
USD ($)
numberOfIncentivePlan
period
$ / shares
shares
Jan. 31, 2022
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of equity incentive plans (in incentive plans) | numberOfIncentivePlan   2  
Options to purchase common stock outstanding (in shares)   6,629,524 7,984,078
Unrecognized stock-based compensation expense related to stock options | $   $ 112.5  
Stock options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted average stock-based compensation recognition period   1 year 10 months 24 days  
RSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted average stock-based compensation recognition period   3 years 1 month 6 days  
Unrecognized compensation costs related to unvested restricted stock units | $   $ 1,304.0  
Number of shares granted in period   6,087,249  
Granted (in dollars per share) | $ / shares   $ 121.08  
Market-based RSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares granted in period 58,150    
Award vesting period 3 years    
Granted (in dollars per share) | $ / shares $ 244.73    
Market-based RSUs | Performance period one      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 33.00%    
Market-based RSUs | Performance period two      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 33.00%    
Market-based RSUs | Performance period three      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 33.00%    
ESPP      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted average stock-based compensation recognition period   7 months 6 days  
Unrecognized compensation costs related to unvested restricted stock units | $   $ 15.2  
Consecutive offering period   12 months  
Number of purchase periods | period   2  
Purchase period   6 months  
Shares of employee purchased Class A common stock (in shares)   269,814  
Weighted-average purchase price of employee purchased Class A common stock (in dollars per share) | $ / shares   $ 70.27  
Total proceeds from employee purchase of Class A common stock | $   $ 19.0  
Minimum | Market-based RSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Earn rate, percent of shares granted 0.00%    
Maximum | Market-based RSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Earn rate, percent of shares granted 200.00%    
Auth0 and atSpoke | Restricted stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted average stock-based compensation recognition period   1 year 6 months  
Unrecognized compensation costs related to unvested restricted stock units | $   $ 172.4  
Number of shares granted in period     1,269,008
Award vesting period     3 years
Granted (in dollars per share) | $ / shares     $ 268.98
2017 Equity Incentive Plan | Class A Common Stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Options to purchase common stock outstanding (in shares)   1,841,836  
2017 Equity Incentive Plan | Class B Common Stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Options to purchase common stock outstanding (in shares)   4,787,688  
v3.22.2.2
Employee Incentive Plans - Schedule of Common Stock Reserved for Future Issuance (Details)
Oct. 31, 2022
shares
Class of Stock [Line Items]  
Common stock reserved for future issuance and options and unvested RSUs outstanding (in shares) 48,883,827
Stock Options and Restricted Stock Units  
Class of Stock [Line Items]  
Stock options and unvested RSUs outstanding (in shares) 15,807,738
Common stock, reserved for future issuance (in shares) 26,022,656
ESPP  
Class of Stock [Line Items]  
Common stock, reserved for future issuance (in shares) 7,053,433
v3.22.2.2
Employee Incentive Plans - Schedule of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 9 Months Ended 12 Months Ended
Oct. 31, 2022
Jan. 31, 2022
Number of Options     
Number of options, outstanding beginning of period (in shares) 7,984,078  
Number of options, granted (in shares) 0  
Number of options, exercised (in shares) (1,177,880)  
Number of options, expired (in shares) (24,833)  
Number of options, forfeited (in shares) (151,841)  
Number of options, outstanding end of period (in shares) 6,629,524 7,984,078
Vested and exercisable, number of options (in shares) 5,855,640  
Weighted- Average Exercise Price     
Options outstanding, weighted average exercise price beginning of period (in dollars per share) $ 39.59  
Options granted, weighted average exercise price (in dollars per share) 0  
Options exercised, weighted average exercise price (in dollars per share) 12.41  
Options expired, weighted average exercise price (in dollars per share) 195.71  
Options forfeited, weighted average exercise price (in dollars per share) 62.73  
Options outstanding, weighted average exercise price end of period (in dollars per share) 43.30 $ 39.59
Vested and exercisable, weighted average exercise price (in dollars per share) $ 27.07  
Additional Disclosures    
Options outstanding, weighted average remaining contractual term 4 years 7 months 6 days 5 years 2 months 12 days
Options outstanding, aggregate intrinsic value $ 249,207 $ 1,314,031
Vested and exercisable, weighted average remaining contractual term 4 years 1 month 6 days  
Vested and exercisable, aggregate intrinsic value $ 242,916  
v3.22.2.2
Employee Incentive Plans - Schedule of Restricted Stock Unit Activity (Details) - RSUs
 9 Months Ended
Oct. 31, 2022
$ / shares
shares
Number of RSUs  
Beginning balance (in shares) | shares 6,225,747
Granted (in shares) | shares 6,087,249
Vested (in shares) | shares (1,956,194)
Forfeited (in shares) | shares (1,178,588)
Ending balance (in shares) | shares 9,178,214
Weighted- Average Grant Date Fair Value Per Share  
Beginning balance (in dollars per share) | $ / shares $ 207.26
Granted (in dollars per share) | $ / shares 121.08
Vested (in dollars per share) | $ / shares 177.54
Forfeited (in dollars per share) | $ / shares 195.91
Ending balance (in dollars per share) | $ / shares $ 157.90
v3.22.2.2
Employee Incentive Plans - Schedule of Estimated Fair Value Assumptions (Details)
 3 Months Ended 9 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Oct. 31, 2022
Oct. 31, 2021
Minimum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expected volatility     63.00% 47.00%
Expected term (in years)     6 months 6 months
Risk-free interest rate     2.46% 0.06%
Maximum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expected volatility     78.00% 48.00%
Expected term (in years)     1 year 1 year
Risk-free interest rate     2.92% 0.09%
ESPP        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expected dividend yield 0.00% 0.00% 0.00% 0.00%
ESPP | Minimum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expected volatility 0.00% 0.00%    
Expected term (in years) 0 years 0 years    
Risk-free interest rate 0.00% 0.00%    
ESPP | Maximum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expected volatility 0.00% 0.00%    
Expected term (in years) 0 years 0 years    
Risk-free interest rate 0.00% 0.00%    
v3.22.2.2
Income Taxes (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Oct. 31, 2022
Oct. 31, 2021
Income Tax Disclosure [Abstract]        
Provision for (benefit from) income taxes $ 3,728 $ 667 $ 9,804 $ (6,785)
Pretax losses $ 205,169 $ 220,644 $ 652,278 $ 614,010
Effective income tax rate (1.80%) (0.30%) (1.50%) 1.10%
v3.22.2.2
Net Loss Per Share - Schedule of Basic and Diluted Net Loss Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Oct. 31, 2022
Oct. 31, 2021
Numerator:        
Net loss $ (208,897) $ (221,311) $ (662,082) $ (607,225)
Denominator:        
Weighted-average shares outstanding, basic (in shares) 158,708 153,756 157,344 145,782
Weighted-average shares outstanding, diluted (in shares) 158,708 153,756 157,344 145,782
Net loss per share, basic (in dollars per share) $ (1.32) $ (1.44) $ (4.21) $ (4.17)
Net loss per share, diluted (in dollars per share) $ (1.32) $ (1.44) $ (4.21) $ (4.17)
Class A Common Stock        
Numerator:        
Net loss $ (199,456) $ (211,176) $ (632,425) $ (576,106)
Denominator:        
Weighted-average shares outstanding, basic (in shares) 151,535 146,715 150,296 138,311
Weighted-average shares outstanding, diluted (in shares) 151,535 146,715 150,296 138,311
Net loss per share, basic (in dollars per share) $ (1.32) $ (1.44) $ (4.21) $ (4.17)
Net loss per share, diluted (in dollars per share) $ (1.32) $ (1.44) $ (4.21) $ (4.17)
Class B Common Stock        
Numerator:        
Net loss $ (9,441) $ (10,135) $ (29,657) $ (31,119)
Denominator:        
Weighted-average shares outstanding, basic (in shares) 7,173 7,041 7,048 7,471
Weighted-average shares outstanding, diluted (in shares) 7,173 7,041 7,048 7,471
Net loss per share, basic (in dollars per share) $ (1.32) $ (1.44) $ (4.21) $ (4.17)
Net loss per share, diluted (in dollars per share) $ (1.32) $ (1.44) $ (4.21) $ (4.17)
v3.22.2.2
Net Loss Per Share - Schedule of Potentially Dilutive Securities Excluded from Computation of Diluted Per Share (Details) - shares
shares in Thousands
 9 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 28,799 27,165
Issued and outstanding stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 6,630 8,621
Unvested RSUs issued and outstanding    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 9,120 5,221
Unvested market-based RSUs issued and outstanding    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 116 0
Unvested restricted stock awards issued and outstanding    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 743 1,269
Shares committed under the ESPP    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 597 213
Shares related to convertible senior notes | 2023 convertible senior notes    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 108 356
Shares related to convertible senior notes | 2025 convertible senior notes    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 5,617 5,617
Shares related to convertible senior notes | 2026 convertible senior notes    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 4,820 4,820
Shares subject to warrants related to the issuance of the 2023 Notes    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 1,048 1,048
v3.22.2.2
Net Loss Per Share - Narrative (Details)
Oct. 31, 2022
$ / shares
2023 convertible senior notes  
Debt Instrument [Line Items]  
Value of shares issuable under warrants granted (in dollars per share) $ 68.06